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Abstract 
The objective of this thesis was to evaluate the toxicity of silver nanoparticles at predicted 
environmentally relevant concentrations (i.e. 0.01, 0.1, 0.5 and 1.0 mg/L by mass of 
nanoparticles). One concentration of silver nitrate (0.01 mg/L) was included to compare the 
effects of silver ions (from AgNO3) with effects of the same concentration of nanoparticles. 
Zebrafish (Danio rerio) larvae were exposed in a critical window of larval development (i.e. 
6 dpf – 21 dpf) to quantify effects on survival, growth and changes in gene expression. 
Suspended nanoparticles were found to be polydispersed and there was a tendency towards 
broader size distributions and bigger agglomerates with increasing concentration. No 
negative effects were observed in survival or growth. However, exposure to the highest 
concentration of silver nanoparticles (0.01 mg/L) resulted in a significant positive effect on 
survival. Microbiological analysis of water samples from the exposure tanks showed that 
there were more microorganisms in the sample collected from the highest exposure 
concentration, indicating that increased survival was most likely not explained by 
antibacterial properties of silver nanoparticles. Changes in gene expression following 
exposure to equal concentrations of silver nanoparticles and silver nitrate (i.e. 0.01 mg/L) 
resulted in distinctive gene expression profiles, with silver nanoparticles inducing changes in 
a much higher number of genes than silver nitrate. Both gene expression profiles appear to 
associate with the visual system and cardiovascular health. Silver nanoparticles induce 
changes in several genes involved in the negative feedback-loop of the circadian rhythm 
system and pathways associated with the activation of nuclear receptors. 
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Abbreviations 
A    Average expression 
Ag     Silver 
Ag+    Silver cation 
Cl-    Chloride 
AgNO3    Silver nitrate 
AAALAC Association for Assessment and Accreditation of Laboratory 
Animal Care International 
ANOVA Analysis of variance 
Artemia   Brine shrimp   
AZlab    Aleström Zebrafish lab 
BA    Blood agar 
cDNA    Complementary DNA 
Chlamydomonas reinhardtii Green algae 
cRNA    Complementary RNA 
CT    Cycle threshold 
CTP    Cytidine triphosphate 
Cyprius carpio  Carp 
Cy3    Cyanine-3 
Cy5    Cyanine-5 
Danio rerio   Zebrafish 
DLS    Dynamic light scattering 
DNA    Deoxyribonucleic acid 
DNase    Deoxyribonuclease 
Dpf    Days post fertilization 
Drosophila   Fruit fly 
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E    Amplification efficiencies 
GAL    Gene pix array list 
GH    General hardness 
HCl    Hydrochloric acid 
IPA    Ingenuity Pathway Analysis 
Kcps    Kilo-counts per seconds 
KH    Carbonate hardness 
limmaGUI   Linear models for microarrays graphical user interface 
Lymnae stagnalis  Freshwater snail 
L929    Mouse fibroblast cells 
M    Fold change ratio 
mRNA   Messenger RNA 
NaOH    Sodium hydroxide 
Neris diversicolor  Polychaete 
NVH    Norwegian school of veterinary science 
PCA    Plate count agar 
TEM    Transmission electron microscopy 
NH3    Ammonia 
NH4+    Ammonium 
NO2-    Nitrite 
NO3-    Nitrate 
OECD The Organization for Economic Co-operation and 
Development 
Oryzias latipes Japanese medaka 
PC12 Rat neuroendocrine cells 
PDI Polydispersity index 
PECs    Predicted environmental concentrations 
qPCR    Real-time quantitative polymerase chain reaction 
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RNA    Ribonucleic acid 
RNase    Ribonuclease 
ROS    Reactive Oxygen Species 
Rpm    Revolutions per minute 
SE    Standard error 
Z.avg    Mean hydrodynamic diameter 
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1. Introduction 
Nanoparticles are commonly defined as particles with at least one dimension between 1 and 
100 nm. It is the inverse relationship between particle size and reactivity that provides 
nanoparticles with the unique mechanical, electrical and optical properties, which are 
exploited in many applications of nanotechnology (Donaldson et al. 2004; Oberdörster et al. 
2005). 
1.1 Nanosilver 
Silver nanoparticles are one of the most common types of nanoparticles in use and were 
chosen for this study because of their wide area of application and that they are known to 
induce toxicity in a variety of cells types (Farkas et al. 2010; Morones et al. 2005; Skebo et 
al. 2007). Their wide range of application is mainly due to their antibacterial properties. 
Nanosilver can be found in a variety of commercially available products such as technical 
textiles, cosmetics, refrigerators, food packing, washing machines etc (Wijnhoven et al. 
2009). Analyses of effluents from a washing machine containing nanosilver  
With the increased production volume and use of nanotechnology-based products comes the 
concern about the toxicity that might be triggered by unintentionally or deliberately exposure 
to silver nanoparticles (Balbus et al. 2007; Chaloupka et al. 2010; Faunce & Watal 2010). 
Exposure models based on current knowledge and production volume have estimated 
predicted environmental concentrations (PECs) of nanoparticles in different compartments to 
be in the low range (mg/kg or ng/L) (Gottschalk et al. 2009; Mueller & Nowack 2008). It has 
just recently been demonstrated that several aquatic organisms accumulate silver 
nanoparticles when exposed to concentrations in the low range predicted to occur in water 
(Cong et al. 2011; Croteau et al. 2011; Gaiser et al. 2009), which raises concern about the 
possible impacts. 
It is well known from studies of ultrafine particles that deposition in the respiratory system 
and toxicity are dependent on the particle size and surface area (Oberdörster 2000). Particles 
deposited in the alveolar region may be phagocytosed by alveolar macrophages and cleared 
from the lungs via the mucociliary escalator. Activation of macrophages may trigger 
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pathological damage in the lung through the release of pro-inflammatory cytokines and 
formation of reactive oxygen species (ROS) (Maynard & Kuempel 2005). 
Assessments of pulmonary uptake have shown that inhaled nanoparticles, including 
agglomerates, appear to be phagocytosed by alveolar macrophages in rats and mice 
(Stebounova et al. 2011; Takenaka et al. 2001). Silver nanoparticles have also been observed 
to redistribute from the lungs and after oral administration, into the systemic circulation and 
reappear in various organs, such as the liver, kidney, spleen, brain, heart and testis of mice 
and rats (Park et al. 2010a; Takenaka et al. 2001). 
A large proportion of inhaled nanoparticles have been found to deposit in the nasal cavity of 
rodents (Takenaka et al. 2001). Particles deposited in the nasal region have previously been 
found to be transported to the olfactory bulb via olfactory nerves and raises concern about 
the ability of nanoparticles to induce neurotoxic effects (Oberdörster et al. 2004). 
Nanosilver have been demonstrated to possess a higher capability to cross the blood-brain 
barrier in rats via subcutaneous injection relative to silver particles in the micro size (Tang et 
al. 2008). Further, in vitro studies conducted with rat neuroendocrine cells (PC-12) have 
found silver nanoparticles to be internalized and to be potent in inducing proinflammatory 
responses and cytotoxicity in rat neuroblast and microvessel endothelial cells (Schrand et al. 
2008; Skebo et al. 2007; Trickler et al. 2010). 
In vitro assays have demonstrated that nanoparticles are capable of being taken up in a 
variety of cell types and to accumulate in cellular compartments, such as the nucleus and 
mitochondria (Asharani et al. 2009; Asharani et al. 2008; Choi et al. 2010; Mahmood et al. 
2010). There is substantial evidence that silver nanoparticles induce cytotoxic and genotoxic 
effects in vitro, through mechanisms interfering with mitochondrial function, membrane 
integrity, formation of reactive oxygen species (ROS), DNA damage and cell death (Arora et 
al. 2008; Asharani et al. 2009; Braydich-Stolle et al. 2005; Farkas et al. 2010; Foldbjerg et 
al. 2011; Hsin et al. 2008; Hussain et al. 2005; Park et al. 2010b; Schrand et al. 2008). 
Further, it has been demonstrated that silver nanoparticles give rise to significant DNA 
damage in cells in a dose-dependent manner (Asharani et al. 2009) and that nanoparticles 
induce apoptosis more significantly in mouse fibroblast cells (L929) than silver 
nanoparticles in the micro-size (Wei et al. 2010). 
 13 
There is controversy whether the observed toxicity is induced by the nanoparticles itself or 
through the dissolution and release of silver ions (Ag+). Nanoparticles have also been 
suggested to induce toxicity by releasing ions at the target site (Choi et al. 2010). The effects 
of silver nanoparticles are often compared to that induced by free ions after exposure to 
silver nitrate (AgNO3), which functions as an ion source. When comparing toxicity of silver 
nanoparticles and AgNO3 to photosynthesis of green algae (Chlamydomonas reinhardtii) as 
a function of Ag+ in the original suspensions it seems that nanoparticles induce a much 
higher toxicity, which cannot solemnly be explained by the original Ag+ (Navarro et al 
2008). Silver ions and nanoparticles have been found to result in distinct responses in the 
gene expression in both medaka (Oryzias latipes) and zebrafish and indicate that they work 
through different mechanisms (Chae et al. 2009; Griffitt et al. 2009). Studies comparing the 
effects on survival at an early life stage of several fish species have discovered nanoparticles 
to be more toxic than silver nitrate indicated by a lower survival in embryos exposed to 
nanoparticles (Chae et al. 2009; Laban et al. 2010). These results are in contrast to another 
reporting indicating that that Ag+ caused lower survival than silver nanoparticles (Yeo & 
Yoon 2009). Comparisons of metal burden measured in gills of adult zebrafish exposed in 
vivo found that silver nanoparticles caused higher silver burden than silver ions (Griffitt et al. 
2009), whilst more silver was found to accumulate in primary cells of gill epithelia cultured 
in vitro and exposed to silver nitrate compared to the same concentration of silver 
nanoparticles (Farkas et al. 2011a). 
1.2 Size, size distribution and state of agglomeration 
The behavior and fate of nanoparticles in biological systems is attributed to the stability of 
the particles in relevant media, which may be affected by a variety of environmental and 
biological factors (ionic strength, temperature, organic material, biological processes etc.), in 
addition to the particles shape, surface chemistry, surface area and state of agglomeration 
(Cumberland & Lead 2009; Fubini et al. 2010; Liu et al. 2011). The attractive forces 
between nanoparticles in suspension increase inversely with particle size and it has been 
demonstrated to be nearly impossible to avoid agglomeration of nanoparticles when 
introduced into test systems (Brain et al. 2009; Powers et al. 2007; Römer et al. 2011). 
Agglomeration shifts the size distribution to higher sizes and may alter the toxicological 
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properties of the primary particles under study (Balbus et al. 2007; Dhawan et al. 2009; 
Fubini et al. 2010). 
There are various strategies available to increase the stability and dispersion of nanoparticles 
in toxicological studies. Addition of sound energy (by an ultrasonicator) agitate 
nanoparticles in suspension and may increase dispersion in the sample (Dhawan et al. 2009; 
Laban et al. 2010), or one can mitigate surface reactivity by coating with polymers or 
suspend the particles in stabilizing agents (Dhawan et al. 2009; Skebo et al. 2007). 
To be able to investigate the significance of size in toxicological studies it is necessary to 
characterize the size, size distribution and agglomeration of nanoparticles in relevant 
medium (Balbus et al. 2007; Dhawan et al. 2009; Powers et al. 2007). Available methods for 
characterization of size and state of agglomeration (e.g. optical spectroscopy, dynamic light 
scattering, transmission or scanning electron microscopy) are based on various 
physiochemical principles, and because the different methods often are inconclusive, it is 
recommended to apply more than one method for the characterization (Dhawan et al. 2009; 
Jones & Grainger 2009; Powers et al. 2007). In this study, there were applied two methods 
for characterization, i.e. dynamic light scattering (DLS) and transmission electron 
microscopy (TEM).  
DLS can be applied for quantitative assessments of the hydrodynamic diameters of 
nanoparticles in suspension. A colloid dispersion is illuminated with laser and the time-
dependent fluctuations in the intensity of scattered light is analyzed and used for calculations 
of the hydrodynamic diameter of the particles (performed by the instrument software) 
(Kaszuba et al. 2008). The hydrodynamic diameter is related to the diffusion coefficient of 
molecules undergoing Brownian motion and is the diameter of a sphere that has the same 
translational diffusion coefficient as the particle being measured (Kaszuba et al. 2008). Sizes 
measured by DLS are intensity-weighted sizes, which mean that the size distributions are a 
plot of the relative intensity of light scattered by particles in various size classes. The output 
reports the mean hydrodynamic diameter and estimated width of distribution (polydispersity 
index). Reported average count rate (number of photons detected per second) can be used for 
evaluating sample quality. Increased count rates indicate agglomerating samples, while 
lower count rates indicate sedimenting or dissolving samples. 
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A common method used for assessments of metallic nanoparticles in toxicological studies is 
the imaging of dehydrated samples of stock or test solutions by TEM (Jones & Grainger 
2009). Analyses of nanoparticles based on TEM images can be used for both quantitative 
assessment of size and size distribution by examination of sufficient particles to provide 
statistically valid results, and qualitative assessment of particle morphology, size distribution 
and state of agglomeration in the samples under investigation (Powers et al. 2007; Tiede et 
al. 2008). 
1.3 The zebrafish model in toxicological assessments 
In vitro assays are simplified models designed for assessments of cellular uptake and toxicity 
(Jones & Grainger 2009) and have been demonstrated to be of limited value for predicting 
the toxicological outcome of nanoparticle toxicity in vivo (Sayes et al. 2009). Zebrafish is a 
tropical freshwater fish of the Cyprinid family originating from South-Asia, which is a 
popular vertebrate model species in biological research and used for toxicological screening 
of new chemicals, including assessments in nanotoxicology (Fako & Furgeson 2009; Hill et 
al. 2005). Zebrafish has been used in biological research since the 1930s and there is 
extensive information on its development, physiology and biochemistry. The sequencing of 
the zebrafish genome was initiated by the Wellcome Trust Sanger Institute (Hinxton, UK) in 
2001 and is now near completed (http://www.sanger.ac.uk/Projects/D_rerio/). The zebrafish 
genome appears to be highly homogeneous to the mammalian, which makes studies of 
toxicological endpoints in zebrafish useful for prediction of toxicity in both aquatic 
organisms and mammals (Aleström et al. 2006; Hill et al. 2005; Zhang et al. 2003). 
The small size, robustness, reproductive capacity and short generation time makes it relative 
easy and inexpensive to maintain zebrafish under experimental conditions. Adult fish grow 
to about 5-6 cm in length and have the capacity to produce 200-300 eggs per spawning if 
handled under appropriate conditions. The developing embryo is transparent and surrounded 
by a chorion until hatching occurs 2-3 days post fertilization (dpf), when most of its 
morphogenesis is completed. Hatched larvae are raised in small containers (1-2 L) under 
semi-static conditions, which require daily replacement of at least 1/3 of the water in the 
containers until they are big enough to be transferred to bigger tanks connected to a flow-
through system (Westerfield 2000).  
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Foraging starts after the yolk is depleted around 4-6 dpf, followed by a critical period of 
extensive growth and subsequent natural drop in survival dependent on the foraging success 
(Kimmel et al. 1995). This time period from around 6 dpf – 21 dpf has been observed to be a 
sensitive window for assessing toxic effects of contaminants in fish (Andersen et al. 2003; 
Bourrachot et al. 2008; Powers et al. 2010). An advantage with exposing zebrafish larvae in 
this period is that they are not dependent on a flow-through system and one avoids the risk 
for contaminating the laboratory circulating system with the test substance. 
Several manufacturers have constructed microarrays of zebrafish complementary DNA or 
oligonucleotides, enabling genome wide transcription profiling of effects following exposure 
to a toxicant, proved to be promising in the search for relevant biomarkers and endpoints for 
toxicity (Nel et al. 2006). 
Microarrays consists of a number of probes made of known oligonucleotides (or 
complementary DNA), which is printed in a matrix on a solid slide and allows the analysis 
of several thousands genes simultaneously. Changes in the gene expression (fold change) 
induced by exposure to toxicants can be examined by quantification of intensity ratios of red 
and green fluorescence that arise from the hybridization of reverse transcribed messenger 
RNA (mRNA) isolated from exposed samples relative to the levels in the unexposed (Nuber 
2005). The quality of the data generated by microarrays is dependent on both biological and 
technical variations, which may be avoided by good experimental design and through the 
processing and normalization of the generated data (White & Salamonsen 2005). 
Normalization of the fluorescence intensities within arrays (print-tip group locally weighted 
scatterplot smoothing) and between arrays (scale) is crucial to eliminate technical variations 
in the dataset (Smyth & Speed 2003; Wettenhall & Smyth 2004) and can be performed in the 
limmaGUI (linear models for microarrays Graphical User Interface) package produced for 
Bioconductor’s R. 
A RNA Target file with information about the microarray hybridizations, slide numbers and 
corresponding output file from the image analyses is uploaded to the limmaGUI package 
together with a Gene Pix Array List (GAL) provided by manufacturer of the arrays, which 
describes the size and position of the blocks, the layout of feature-indicators and the names 
and identifiers of the printed substances associated with each feature-indicator. A Spot Type 
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file with information about the color codes and names is optional but and can be uploaded to 
limmaGUI to distinguish between genes, controls and blanks. 
The limmaGUI package fits a linear model to the data, tests the hypothesis that the 
expression values of the genes in the exposed groups is equal to the expressions in the 
unexposed and adjusts the p-values for multiple testing (Smyth 2004; Wettenhall & Smyth 
2004). The adjustment is based on the Benjamini and Hockberg method, which control the 
false discovery rate – a challenge with analysis of large data sets, and means that the 
expected proportion of false positives in the selection is controlled to be less than the 
threshold selected for the analysis, i.e. less than 5 % for a threshold of 0.05 (Smyth 2005). 
MA scatter plots with (log2) fold change ratios (M) plotted against the average expression 
(A) are known to be convenient for visualization of the distribution of induced or repressed 
genes, and assessment of the quality of the microarray data based on the shape of the scatter 
plot (White & Salamonsen 2005). The data are considered of good quality if the spots are 
distributed as an elongated comet around M=0 (White & Salamonsen 2005). 
It is common to analyze a set of genes from the microarray result by real-time quantitative 
polymerase chain reaction (qPCR) in order to validate the fold changes quantified by the 
microarrays (Denslow et al. 2007; Morey et al. 2006). This technique requires appropriate 
primers pairs (forward and reverse) to be designed, to be able to amplify the relevant target 
genes. The SYBR Green assay applied for the qPCR in the present study incorporates a 
fluorescence dye, and the number of amplifying cycles required to generate sufficient 
fluorescence (the cycle threshold) reflects the abundance of the target in the sample. 
CT values need to be normalized to the expression of a gene, which is equally expressed (not 
affected by the exposure) in the samples from both the exposed and unexposed (Tang et al). 
Normalized CT values are analyzed by the Livak method (Livak & Schmittgen 2001) to 
determine the mean fold change of the target genes in the exposed samples relative to the 
fold change in the unexposed. 
Ingenuity Pathway Analysis (IPA, http://www.ingenuity.com) is useful for assessments of 
molecular pathways, canonical pathways (typical pathways known to be associated with 
expression of the identified genes), biological functions and diseases that are most 
significantly associated with the differently expressed genes detected by microarrays. 
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Uploaded gene identifiers (IDs) are uploaded to the online java-based software, which maps 
the IDs to mammalian homologues and corresponding information stored in the Ingenuity 
Knowledge Base. The output from IPA is based on the ratios of the number of molecules 
from the uploaded dataset that map to each pathway, divided by the total of molecules 
identified to be involved in the same pathway. Assigned p-values (calculated by the right-
tailed Fisher’s exact test) determine the probability that the association between genes in the 
uploaded dataset and pathways or biological functions are due to chance alone or can be 
explained by the parameters under investigation. 
1.4 Objective of study 
With the considerable increase in production volume and widespread use of engineered 
silver nanoparticles there is a growing concern about the potential risk associated with 
nanotoxicology. 
The overall objective of this study was to evaluate the toxicity of silver nanoparticles at 
environmentally relevant concentrations during early life development using zebrafish 
as a model organism. 
Zebrafish was chosen as test species to examine the toxicity of silver nanoparticles on both 
the phenotypic and molecular level, and because zebrafish can serve as a model species for 
assessment of the toxicity induced in other vertebrates. 
To evaluate the toxicity of silver nanoparticles at predicted environmentally relevant 
concentrations we exposed zebrafish to a range of low concentrations (by mass of silver 
nanoparticles) and one concentration of AgNO3 to: 
 Characterize the size and size distribution of nanoparticles suspended in exposure 
solutions of different concentrations. 
 Quantify effects on changes in survival in a critical window of larval development 
 Quantify effects on growth based on body length on 21 dpf 
 Clarify and compare changes in gene expression following exposure to a low 
concentration of silver nanoparticles and the same concentration of AgNO3. 
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 Validate the microarray results by qPCR 
 Clarify if the amount of microorganisms in fish tank water could explain differences 
in survival. 
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2. Materials and methods 
2.1 Nanoparticles and silver ion source 
Silver (Ag) nanoparticles from PlasmaChem GmbH (Berlin, Germany) were provided as dry 
powder by the NanEAU project. The nominal size was specified to be 20 nm by the 
manufacturer. Silver nitrate (AgNO3, CAS-no.: 7761-88-8) was applied as a silver ion source 
and was purchased from Sigma-Aldrich AS, Schnelldorf, Germany. Both particles and 
reagent were stored at room temperature away from light until required. 
Fresh stock solutions with nominal concentrations of 1000 mg/L by mass of nanoparticles or 
silver nitrate powders were made every third day during the exposure period and stored at 
room temperature in a dark cabinet when not in use. 
Silver nanoparticles (13 mg) and silver nitrate (13 mg) were weighed out in 50 mL-Falcon 
tubes on a milligram scaled weight. Autoclaved ultrapure water (11 mL) (Simplicity UV 
water purification system, Millipore Molsheim, France) was added to each tube before the 
powders were resuspended. Nanoparticle suspensions were mixed on a Labinco L46 vortexer 
and sonicated on ice with an UP200S ultrasonic processor (Hielscher Ultrasound, GmbH) for 
3 min until 420 J of total energy was supplied to the solutions. Conditioned water from the 
zebrafish lab (2 mL) was added to the stock solutions to achieve a stock concentration of 
1000 mg/L by mass of nanoparticles or reagent powder. Conditioned water (0.8 L) was 
added to each tank and spiked (Table 1) with stock solutions of silver nanoparticles or 
AgNO3 to achieve nominal concentrations of 0.01, 0.1, 0.5 and 1.0 mg/L by mass of 
nanoparticle or reagent powder. 
Table1. Amount of stock solution used to spike the conditioned water to appropriate concentrations. 
Stock solutions (1000 mg/L) were diluted in 0.4 L conditioned water at 50 % water change and 0.8 L 
conditioned water at 100 % water change. Conditioned water contained methylene blue. 
Experimental group 50 % water change 100 % water change 
Control 0.4 L conditioned water 0.8 L conditioned water 
AgNO3 0.01 mg/L 4 µL stock 8 µL stock 
Ag nano 0.01 mg/L 4 µL stock 8 µL stock 
Ag nano 0.1 mg/L 40 µL stock 80 µL stock 
Ag nano 0.5 mg/L 200 µL stock 400 µL stock 
Ag nano 1.0 mg/L 400 µL stock 800 µL stock 
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Experimental tanks were filled with respective concentrations and drained before the 
exposure solutions and larvae were added and prior to renewal of tanks in order to minimize 
reduction of the nominal concentrations through adhesion of the test particles or reagent to 
the plastic tanks (Scown et al. 2010). 
2.2 Characterization 
Characterization of the nanoparticles suspended in the test media were performed by DLS, 
using a Zetasizer Nano Series instrument (Malvern instrument) and was performed at 
Radiumhospitalet on the fourth day in the exposure period (9 dpf). Samples from one 
replicate tank from each of the nanosilver groups, the control group and a sample of 
conditioned water were collected with disposable pipettes (VWR International, Oslo, 
Norway) and transferred to respective Eppendorf tubes. 
At Radiumhospitalet each sample (100 µL) were transferred to transparent disposable 
cuvettes (Malvern, UV-cuvette micro). Mean hydrodynamic diameter (Z.avg), size 
distributions and polydispersity index (PDI) values were characterized by DLS, at 25±1°C 
and scattering angel of 173°. 
There were collected samples from the exposure tanks for characterization by TEM on the 
same day as for the DLS characterizations (9 dpf). One droplet (~ 20 µL) from each sample 
was applied on carbon coated formvar copper grids (100 meshes) and excess fluid was dried 
by careful blotting with a filter paper as described by Bar-Ilan et al., 2009. Stock solution 
prepared for TEM assessments were allowed to attach for 10-15 min on the copper grid 
without blotting, as the assessments of the blotted samples appeared to result in few particles 
on the grid. 
Samples were investigated by a Philips EM208S transmission electron microscope at 80 kV, 
the intensity adjusted to ~ 50% (± 1.0%) before the iTEM 5.0 software (Olympus Soft 
Imaging Solutions GmbH, Münster, Germany) was used to generate two-dimensional 
images of the nanoparticles in the dehydrated sample. 
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2.3 Test organisms and experimental design 
Fish husbandry and exposure were carried out in the Aleström Zebrafish Lab (AZlab) at the 
Department of Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary 
Science (NVH), Oslo, Norway.The Aleström zebrafish lab follows general guidelines for 
zebrafish care and husbandry and have since 1st of July 2008 been accredited by the 
Association for Assessment and Accreditation of Laboratory Animal Care International 
(AAALAC). 
Adult AB wild type zebrafish (in house stock of the AZlab and adult AB wild type fish 
purchased from the Zebrafish International Resource Centre, Eugene, OR, USA) were bred 
to obtain sufficient number of larvae for the experiment. Two males and two females were 
placed in breeding tanks (2 L) and left over night. The genders were separated by a 
transparent barrier in each tank, resulting in a total of 32 tanks. Barriers were removed the 
next morning when lights were switched on and the fish were left alone to spawn for 2- 4 h. 
Eggs were collected from the bottom of each tank after 2 h and 4 h by pouring the tank water 
through a sieve. Collected eggs were rinsed with autoclaved conditioned water before they 
were transferred to petri dishes (90 mm, VWR International, Oslo, Norway) containing fresh 
autoclaved conditioned water. 
Dead embryos were removed daily and the number of viable embryos were registered and 
evenly distributed in petri dishes, resulting in <100 embryos in each petri dish. 
Embryos/larvae in respective petri dishes were incubated in 28°C from the day of 
fertilization (0 dpf) until 5 dpf. Viable embryos/larvae were registered on a daily basis and 
dead individuals were removed. 
Bleaching of embryos ∼ 24 h post fertilization is a standard operating procedure at the AZlab 
and recommended in the Zebrafish Book (Westerfield 2000) to avoid contamination and 
spread of infection. 
Approximately 24 h post fertilization the respective beakers (1 L) were filled with acquired 
solutions for the bleaching procedure Dead embryos were removed before each batch (< 100 
individuals) of healthy embryos were transferred to a filter and the procedure carried out by 
periodically swirling of the filter in each beaker with fresh solutions adjusted to pH 7.0-7.5 
by adding drops of HCl (1M) or NaOH (1M). 
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The procedure started with 5 min in bleach solution (85 % sodium hypochlorite and 
autoclaved conditioned water, pH 7.0), followed by 1 min in a second beaker containing 
sodiumthiosulfate (pH 7.0) and rinsed twice for 1 min each in two beakers containing rinse 
solution (autoclaved conditioned water, pH 7.5). After bleaching the number of viable 
embryos was counted and equal numbers of individuals were randomly distributed to new 
petri dishes (<100 embryos per 90 mm-petri dish). 
There was a problem with fungal growth and an increased mortality rate in the first 
experimental set up. To avoid the problem of fungal growth a decision was made to add a 
0.05% methylene blue stock solution (500 µL) to the conditioned water (1 L) used for the 
exposure on 7 dpf, resulting in a final concentration of 0.25 mg/L. This is a standard 
operating procedure at the AZlab during larvae husbandry and commercially available 
aquarium product. 
On 5 dpf an equal number of larvae were transferred to each exposure tank (1 L), resulting in 
52 individuals in each replicate tank and left alone to acclimate until the exposure start on 6 
dpf. One exposure group consisted of 5 replicate tanks and there were six exposure groups in 
total (n=5). Five groups were exposed to silver nanoparticles (e.g. 0.01, 0.1, 0.5 and 1 mg/L), 
one group to silver nitrate (0.01 mg/L) and there was included one control group with 
conditioned water and methylene blue. 
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Figure 1. Photography of exposure tanks in the aquaria room in the AZlab.The experimental groups 
were distributed on two shelves and replicate tanks belonging to the same group were placed 
together. The air pumps in this photo were not connected to the system. The blue color is from the 
methylene blue. 
2.3.1 Physical and chemical parameters 
To ensure optimal conditions the larvae were kept in static tanks with renewal of 50% of the 
water and respective nominal concentrations on a daily basis. Tanks were changed twice a 
week. On 6 dpf the experimental tanks were placed in one of the aquaria rooms in the AZlab 
holding an ambient temperature of 25 ± 1°C and a light: dark regime of 14:10 h. Dead 
individuals, excess feed and debris were removed on a daily basis with a disposable pipette. 
The staff in the zebrafish lab produced conditioned water continuously. Water quality 
parameters (e.g. pH, NO2-, NO3-, NH4+/NH3, salinity, degrees of general hardness (GH), 
degrees of carbonate hardness (KH), temperature and conductivity) were adjusted to be 
within healthy range prior to use (i.e. conditioned). The temperature in the exposure tanks 
was measured every day and water quality parameters (e.g. pH, NO2-, NO3-, NH4+/NH3, GH, 
KH, O2 and conductivity) tested on the day of exposure start, 8 dpf and 14 dpf by the Tetra 
test laborette (GH, KH, NH4, NO3, NO2 and O2), Hanna instruments (conductivity) and a pH 
meter. 
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The recorded values in the experimental tanks were generally within the recommended 
values of the AZlab (Table 2). 
Table 2. Physical parameters in the exposure tanks measured on 6, 8 and 14 dpf. The healthy range 
is the values recommended in the standard operating procedures of the AZlab. 
Parameter Healthy range* 6 dpf 8 dpf 14 dpf 
pH 7-8 7.32 7.22 7.26 
NO2- (mg/L) <0.1 <0.3 <0.3 <0.3 
NO3- (mg/L) <50 0 0 0 
NH4+, NH3 (mg/L) <0.1 0 <0.3 0 
dGH 2-8 2 2 2 
dKH 3-8 2 2 2 
Conductivity (s/cm) 400-600 378 383 413 
Temperature (°C) 26-30 26.1 24.0 24.2 
* Recommended by the AZlab 
2.3.2 Feeding regime 
Starting on 6 dpf, the larvae were fed ~ ¼ of a spatula with dry feed (SDS 100, Scanbur AS, 
Nittedal, Norway) four times a day. To avoid overfeeding, the amount was adjusted on a 
daily basis by looking for excess feed after 10 min. 
From 13 dpf the larvae were fed one droplet of Artemia nauplii (Grade 0, Platinum Label, 
Argent Laboratories, Redmond, USA) from a disposable pipette twice a day in addition to 
twice with ~ ¼ of a spatula with dry feed. 
2.4 Studied endpoints 
2.4.1 Survival 
Starting on 6 dpf dead individuals were counted in each replicate tank and survival registered 
each day until the last day of the study period (21 dpf). 
2.4.2 Growth 
After the larvae were euthanized at 21 dpf the body length of each larvae were measured 
with an mm-scaled ruler. The length was measured from the tip of the head to the tip of the 
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tail as displayed in the Figure 2. A plastic forceps was used to arrange the larvae next to the 
ruler and the length recorded in centimeters with two decimals. 
 
Figure 2. The length of each larva sampled for microarray analysis was measured from head to tail 
with an mm-scaled ruler as displayed in the photography. 
2.5 Microbiological analysis 
It was decided to collect water samples (100 mL for each group, consisting of samples of 
equal amounts from each replicate) for microbiological investigations to be able to 
investigate whether microbiological contamination could be a potential factor affecting 
survival. 
The samples were plated out on blood agar (BA) and plate count agar (PCA) at room 
temperature and incubated in 30°C for 24 h before the number of bacterial colonies on each 
plate were counted manually. Investigations of water samples from the lowest concentration 
(0.01 mg/L) of silver nanoparticles were not conducted due to problems with the sample 
preparation for counting. The plating out and microbiological investigations were carried out 
by staff at the Microbiology and Hygiene laboratory at NVH. 
2.6 Sampling and isolation of material for gene expression 
analyses 
On 21 dpf, all fish were euthanized with an overdose of benzocaine (100 mg/mL) in a fish 
tank placed on ice. 
To ensure adequate biological material for the hybridizations six biological replicates were 
generated from each experimental group by pooling approximately five larvae from each 
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replicate tank (Figure 3) in 2 mL-tubes containing magnalizer beads (Roche Diagnostics, 
Oslo, Norway). The number of sampled individuals from each replicate tank was based on 
the number of larvae that survived the exposure 21 dpf. Samples were snap frozen in liquid 
nitrogen and stored in – 80°C until required. 
2.6.1 Isolation and purification of RNA 
All procedures involving nucleic acids were performed with instruments and on benches 
sterilized with RNeasy away (Qiagen, Oslo, Norway). 
Total RNA was isolated with trizol Reagent (Invitrogen, Oslo, Norway), according to the 
instructions in the manufacturer’s manual. 
Trizol (1 mL) was added to each tube containing magnalizer beads with frozen tissue and 
homogenized for 50 sec at a frequency of 25 using a mixer mill (type MM301, Retsch, Dale 
in Sunnfjord, Norway). The homogenizing was repeated after turning the containers up side 
down. Samples were allowed to sit for 5 min on ice. 
Chloroform (200 µL/mL trizol) was added to the tubes and the solutions were mixed by 
manually shaking the tubes for 15 sec and incubated for 2 min in room temperature. In order 
to separate the organic phase from the aqueous phase containing RNA the incubation step 
was followed by centrifugation at 4000 revolutions per minute (rpm) for 15 min at 2-8°C in 
a Thermo Scientific Heraeus fresco 21 centrifuge (Fisher Scientifics, Oslo, Norway). 
The aqueous phase (500 µL) was added to new micro tubes containing isopropanol of equal 
amounts as the aqueous phase, incubated for 10 min at room temperature and centrifuged at 
4000 rpm for 10 min at 2-8°C. The resulting supernatants were discarded and the 
precipitated pellets containing RNA were stored in – 75°C. 
The next morning the pellets were thawed on ice, vortexed and centrifuged at 4000 rpm in 2-
8°C for 5 min. The resulting supernatants were discarded carefully using a pipette and the 
pellets were left to dry in the tubes. After 5 min RNAse free water (50 µL, Qiagen, Oslo, 
Norway) was added to each RNA pellet, before the solutions were vortexed. RNA 
concentrations were measured by a Nanodrop ND-1000 spectrophotometer (Nanodrop 
Technologies, Delaware, USA) at 260 and 280 nm. Samples (1 µL) of isolated RNA were 
pipetted on the lower measurement pedestal before the sampling arm was closed and 
 28 
measurement initiated. Both lower and upper pedestal were cleaned after each measurement 
using a laboratory wipe. 
Absorbance ratios (260 nm/ 280 nm) of 1.8 – 2.0 and yields exceeding 100 ng/µL were 
considered as acceptable. All values were considered satisfactory (raw data in appendix). 
Before proceeding to the purification step, possible genomic contaminations were removed 
by treating each sample with a mixture of DNase I (2.5 µL DNase I in 10 µL RDD buffer) 
provided by the RNase-Free DNase set (Qiagen, Oslo, Norway). 
To make up a total volume of 100 µL there was added RNase Free water (37.5 µL) to each 
tube, followed by addition of the mixture of DNase I (12.5 µL). The solutions were 
incubated for 10 min at room temperature. 
Purification of RNA was performed with the RNeasy Mini Kit (Qiagen, Hilden, Germany), 
according to the manufacturer’s protocol. The RNeasy Mini Kit is designed for purification 
of small amounts of total RNA isolated from animal cells. Messenger RNA (mRNA) is 
enriched by selective binding of RNA molecules longer than 200 base pairs to a silica 
membrane in the RNeasy spin columns provided in the kit. 
To ensure purification of intact RNA and inactivation of RNase, RLT buffer (350 µL) was 
added to each sample and the solutions were mixed well by pipetting. Membrane binding 
conditions were optimized by addition of 96% ethanol (250 µL), mixed well by pipetting and 
samples (700 µL of each) were transferred to new spin columns, centrifuged at 8000 rpm for 
15 sec in the Thermo Scientific Heraeus fresco 21 centrifuge. The centrifugation was 
repeated after the samples were transferred to new collection tubes. 
After columns were transferred to new collection tubes RPE buffer (700 µL) was added and 
samples centrifuged at 8000 rpm for 15 sec. The flow through from the collection tubes were 
poured off and spin columns centrifuged at 10 000 rpm for 1 min. Traces of ethanol were 
removed from the membranes using a pipette and spin columns were transferred to new 
collection tubes. To elute RNA, RNAse free water (50 µL) was added on top of the 
membranes and allowed to sit for 2-3 min, followed by centrifugation at 10 000 rpm for 1 
min. Spin columns were removed and tubes placed on ice. 
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Three aliquots of each RNA sample were made by transferring 23 µL sample for microarray 
analysis, 23 µl for qPCR and 4µL for quantitative and qualitative check for all experimental 
groups to respective 1.5 mL tubes. Samples were stored in – 75°C until required. 
2.6.2 Qualitative assessment of the isolated RNA 
Quantity (measured by Nanodrop) and quality of the isolated RNA were measured in order 
to minimize variations and thereby improving the following labelling and hybridisation 
process (Forster et al. 2003). 
The quality of the purified RNA (1 µL) was examined with the Agilent 2100 Bioanalyzer 
(Agilent Technologies, California, USA) and the RNA Nano LabChip Kit (Agilent 
Technologies). The principle of the assay is that fragments of nucleic acids are separated by 
size as they are driven electrophoretically through interconnected micro channels on a chip. 
The 2100 expert software (Agilent) was used to generate electropherograms (Figure 3) and 
gel-like images. Calculated RNA Integrity Numbers (RINs) and ratios of ribosomal subunits 
(28s/18s) were used to assess the integrity and detect possible degradation or genomic 
contamination of the isolated RNA. The software RIN algorithm classify the sample from 1 
to 10, with 1 being the most degraded and 10 the most intact. Low ratios of the 28s/18s 
ribosomal subunits indicate that the samples have been prone to degradation processes. 
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Figure 3. Electropherogram of RNA sample from the control group generated by the Agilent 2100 
Bioanalyzer. Integrity time (sec) is displayed on the x-axis and the fluorescence unit (FU) on the y-
axis. High quality samples of RNA produce electropherograms with clear 18S and 28S peaks and 
minimal noise between peaks, as the one displayed here. 
The Bioanalyzer results indicated that all samples were of good quality and showed little 
sign of degradation. Ribosomal ratios ranged from 1.9 – 2.3 and RINs from 7.5 – 10 (mean 
RIN was 9.5). 
2.7 Microarray based gene expression analysis 
Agilent’s Low Input Quick Amp Labelling kit was used for the amplification and labelling 
of samples prior to hybridization. Agilent’s zebrafish (V3) oligonucleotide microarrays 
(Matriks AS, Oslo, Norway) were used for the gene expression analysis. One slide consisted 
of four arrays, with 44 000 probes printed on each array. 
2.7.1 Sample preparation and hybridization 
Sample labelling, amplification, hybridization and microarray wash were performed 
according to Agilent’s protocol for Two-Color Microarray-Based Gene Analysis (Agilent 
Technologies, Inc., Santa Clara, CA, USA). 
18S 
28S 
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Spike mixes with cyanine-3 (mix A) and cyanine-5 (mix B) provided in the Spike-In kit 
(Agilent technologies, CA, USA) were diluted to 1:16 in a serial dilution according to the 
manufacturer’s instructions for a starting sample input of 200 ng total RNA and the spike 
mixes were stored in - 70°C until acquired. 
Spike mixes (2 µL) with cyanine 3-CTP (spike mix A) or cyanine 5-CTP (spike mix B) and 
T7 Promoter Primer Mix (0.8 µL T7 Promoter Primer and 1.0 µL nuclease free water) were 
prepared and added to each tube according to the dye-swap design (Figure 3). Isolated RNA 
from the control group was split in two; one half (A-samples) for labelling with Cy3 and the 
other half with (B-samples) Cy5 to facilitate the dye-swap design. Both samples were made 
to result in a total of approximately 200 ng input RNA for the labelling reaction and 
complementary DNA (cDNA) synthesis. 
 
 
Figure 4. Microarray design. Approximately 5 larvae were sampled from each replicate tank (Rep. A-
E) and pooled in an Eppendorf tube, resulting in one biological replicate. Total RNA from six 
biological replicates were isolated from each exposure group, purified and labelled with Cy3 (red) or 
Cy5 (green). Replicates from the control and exposed groups with opposite labels were hybridized on 
each array (4 arrays on each slide) to achieve a dye-swap experiment. RNA samples from the control 
group were split in two samples (A and B) with equal concentrations. 
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To denature the primer and template were each sample incubated at 65°C for 10 min before 
they were placed on ice for 5 min. A cDNA master mix (4.7 µL) containing 5X First Strand 
Buffer (54 µL), 0.1 M DTT (27 µL), 10 mM dNTP mix (13.5 µL) and AffinityScript Rnase 
Block Mix (32.4 µL) was added to each tube and the solutions were mixed by pipetting 
before incubated in a water bath holding 40°C for 2 h, followed by incubation in another 
water bath of 70°C for 15 min. After incubation the samples were placed on ice for 5 min 
and spinned down in a microcentrifuge (Galaxy mini, VWR International, Oslo Norway). 
The cDNA samples were stored in - 80°C over night. 
On the next day complementary RNA (cRNA) was synthesized by adding Transcription 
master mix (6 µL) to each tube. The Transcription master mix was made of nuclease free 
water (0.75 µL), 5X First Transcription Buffer (3.2 µL), 0.1 M DTT (0.6 µL), NTP mix (1 
µL), T7 RNA Polymerase Blend (0.21 µL) and cyanine 3-CTP or cyanine 5-CTP (0.24 µL) 
provided in the kit. The solutions were mixed by pipetting and incubated for 2 h at 40°C in a 
circulating water bath. 
The Qiagen RNeasy mini kit was used to purify the amplified and labelled cRNA samples, 
according to the kit’s manual. To make up a total volume of 100 µL, nuclease free water (84 
µL) were added to the cRNA samples before proceeding with the purification step. RLT 
Buffer (350 µL) and 96 % ethanol (250 µL) was added to the tubes and mixed well by 
pipetting. The cRNA samples (700 µL) were transferred to RNeasy mini columns and 
centrifuged at 13 000 rpm for 30 sec at 4°C. The RNeasy columns were transferred to new 
collection tubes (2 mL), RPE Buffer (500 µL) was added and the centrifugation step 
repeated before the flow-through in the collection tubes were discarded. Fresh RPE buffer 
(500 µL) was added and the samples were centrifuged at 13 000 rpm for 1 min at 4°C before 
the flow-through and the collection tubes were discarded. Any traces of RPE buffer were 
removed by a pipette and the cRNA samples eluted by addition of RNase free water (30 µL) 
on the RNeasy filter membrane and allowed to sit for 1 min. This was followed by 
centrifugation at 13 000 rpm for 30 sec at 4°C. The flow-through containing the cRNA was 
kept on ice and columns were discarded. 
The Nanodrop spectrophotometer was used to quantify the labelled and amplified cRNA (1 
µL). The recorded dye concentration (pmol/µL) of Cy3 or Cy5, RNA absorbance ratio (260 
nm/280 nm) and cRNA concentration were used to calculate and examine the yield and 
specific activity of each reaction as described in the appendix. Recommended yield was 
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0.825 µg and specific activity recommended to 6 pmol Cy3 or Cy5 per µg cRNA. The yield 
and specific activity ranged from 223 – 521 µg and 27.4 – 37.4 pmol dye per µg cRNA 
respectively and satisfied the recommended values. The labelled and amplified samples were 
stored in -70°C until acquired for hybridization. 
To ensure a sample input of 825 ng cRNA for the hybridization the yield and specific 
activity quantified by Nanodrop were used to calculate the volume of prepared cRNA to be 
added to each microarray (calculations in appendix). Sterile 1.5 mL microcentrifuge tubes 
were prepared for each hybridization and 10X Blocking Agent (11 µL), 25 X Fragmentation 
Buffer (2.2 µL), nuclease free water (to make a total volume of 52.8 µL) were added to each 
tube together with the calculated volume of Cy3-labelled cRNA and Cy5-labelled cRNA. 
Samples were mixed on a Labinco L46 vortexer, incubated at 60°C for 30 min and cooled on 
ice for 1 min in order to fragment the RNA. 
The 2x Gee Hybridization Buffer HI-RPM (55 µL) provided in the kit was added to each 
tube to stop the fragmentation reaction and the solutions were mixed by carefully pipetting 
the solutions up and down. The samples were centrifuged at 13 000 rpm for 1 min at room 
temperature and placed on ice. 
Prepared samples (100 µL) were loaded on respective gasket slides using a micropipette 
before they were covered with the slides containing the microarrays, with the active side 
towards the samples. The slides were placed in a SureHyb hybridization chamber (Agilent 
technologies) and hybridized in an Agilent hybridization oven at 65°C for 17 h. Rotation was 
set to 10 rpm. 
To reduce possible array wash artefacts there were added 10% Triton X-102 (2 mL) 
provided in the kit to the Gene Expression Wash Buffer 1 and 2. The Gene Expression Wash 
Buffer (GE Wash Buffer) 2 was heated over night in a water bath holding 37°C. Wash 
buffers and solutions for washing the microarray slides were prepared in separate 50 mL 
Falcon tubes. After the slides were hybridized in the hybridization oven for 17 h they were 
placed in a Falcon tube containing the GE Wash Buffer 1 at room temperature and the gasket 
slide were removed with a plastic tweezer. The liquid covered the slides. The slides were 
transferred to a second tube with GE Wash Buffer 1 and washed for 1 min at room 
temperature, followed by a wash for 1 min in a tube containing the GE Wash Buffer 2 
(37°C) and finally for 30 sec at room temperature in a tube with Stabilization and Drying 
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solution provided in the kit. The wash procedures were carried out in 50 mL Falcon tubes 
covered in foil on a roller mixer (Stuart scientific SRT1, Sigma Aldrich, UK). 
2.7.2 Microarray scan 
The hybridized slides were scanned using the GenePix 4000B scanner (Molecular Devices, 
CA, USA) and the fluorescence intensity of each dye at each spot on the arrays were 
processed in the GenePixPro 6.0 software in order to quantify the relative abundance of the 
corresponding cDNA probe in the exposed vs. control samples (Dudoit et al. 2002). The 
scanner acquired data from two wavelengths simultaneously by dual photomultipliers 
(PMTs), and the PMT gain values were automatically selected by the scanner. The intensity 
of each spot was adjusted manually to a level close to the saturation level in to minimize 
background signals, maximize spot intensity and avoid saturated (white) spots (Forster et al. 
2003) and the ratios of red (Cy3) and green (Cy5) dye were calculated by the GenePixPro 
software. A GenePix Array List (GAL) was uploaded to the software and fitted to each of 
the images to name and identify each spot on the arrays before further processing of the 
microarray data. 
2.8 Normalization and analysis of microarray data  
The raw data were log transformed (log2) in order to get a more symmetrically representation 
of the intensity ratios. Negative values of red (R) or green (G) intensities were removed from 
the data set (Dudoit et al. 2002; White & Salamonsen 2005) before the fluorescence 
intensities were normalized within arrays (print-tip group locally weighted scatterplot 
smoothing) and between arrays (scale) in the linear models for microarrays Graphical User 
Interface (limmaGUI) package produced for Bioconductor’s R environment to eliminate 
systemic variations in the dataset (Smyth & Speed 2003; Wettenhall & Smyth 2004). A 
RNA Target file, GAL file and Spot Type file were uploaded to limmaGUI as tab-delimited 
text files. 
The limmaGUI package fits a linear model to the data, tests the hypothesis that the 
expression values of the genes in the exposed groups is equal relative to the expressions in 
the unexposed and adjust the p-values for multiple testing (Smyth 2004; Wettenhall & 
Smyth 2004). 
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Figure 6. MA-scatter plots of log-transformed (log2) intensity ratios from the microarray scan for the 
silver nano (0.01 mg/L) group (top) and silver nitrate (0.01mg/L) group (bottom). Y-axis represents 
the intensity log ratio (M) and the x-axis represents the mean log intensity (A). Genes with low fold 
change ratios are centred around M=0. 
The normalized intensity log-ratios M=log2 R/G (y-axis) and mean log intensity A=log2 
√R/G (x-axis) for each probe were plotted in a scatterplot (MA-plot) by a bivariate fit of M 
by A for the two exposed groups and used to set threshold values for excluding genes with 
low intensity ratios (low expression) and genes with low fold change values (log ratios). 
Genes with M values between +0.3 and -0.3 and mean log intensity <6 (low intensity) were 
excluded from the gene lists, before genes assigned adjusted p-values ≤0.05 were selected 
for further analyses in the Ingenuity Pathway Analysis (IPA) software. 
 
AgNO3 
Ag nano 
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2.9 Analysis of changes in gene expression 
The lists of the differently expressed genes, corresponding log ratios and adjusted p-values 
were uploaded to the IPA software to examine responses in the transcriptome after exposure 
to silver nanoparticles and silver nitrate, and to identify the unique and common genes across 
the two datasets. 
Each identifier was mapped to corresponding human, rat or mouse homolog in the Ingenuity 
Knowledge Base and the Core Analysis was used to identify molecular functions, canonical 
pathways, biological functions and diseases most significantly associated with the two 
exposures. Functions and pathways associated with molecules identified to be unique for the 
two exposures were further explored. 
2.10 Validation of microarray results by qPCR 
A total of 10 target genes (Table 3) were randomly selected from the microarray generated 
gene lists for validation of the fold change measured by the microarrays. 
The Superscript III Platinum Two-step qRT-PCR kit with SYBR Green (Invitrogen, Life 
technologies, Norway) was applied for real-time quantification of fold change of 10 target 
genes in aliquots of the same total RNA samples that were used for the microarrays. The kit 
enables a simple, sensitive and reproducible quantification of RNA by the 7900 HT Fast 
Real-Time PCR System (Applied Biosystems, Life technologies). 
The Universal ProbeLibrary Assay Design Center software (Roche Applied Science version 
2.45) was applied to design suitable target specific qPCR primer pairs for the selected genes 
(Table 3). The designed primer pairs were ranked by the software using optimized default 
settings and the top ranked intron-spanning primers closest to the 3’end with an amplicon 
size less than 120 base pairs were selected for the qPCR analysis.  
Table 3. Selected genes and designed primer pairs for validation of the microarray results by qPCR. 
Gene name Gene Forward primer (5ʼ-3ʼ) Reverse primer (5ʼ-3ʼ) 
ATP-binding cassette, 
sub-family A (ABC1), member 1 ABCA1 cttaccctggccaagtgc aaccaggatgctgaccagac 
B-cell receptor-associated protein 31 BCAP31 gatgccgccaagaaatacat cacttcaataccggcttgc 
Biorientation of chromosomesin 
cell division 1 BOD1 aaattcagcccctgatgttg ggcaaaaatccttggacctc 
Phosphogluconate dehydrogenase PGD tgacgggtacagacacgaga gtgcgcaccaaagtagtctct 
Zinc fingers and homeoboxes 2 ZHX2 ccgagaccttgaagtgctgt catagcagcctttttccttcttt 
Aminolevulinate, delta-, synthase 1 ALAS1 ggtcatgcacaagatggaca atgtacccgcccacacag 
Antizyme inhibitor 1 AZIN1 tgaacgatggtgtttatggatct tcatctagggtgagcgacatc 
Hematological and neurological 
expressed 1 HN1 gaacccgaggaccctcat gcagatggttctccacacaac 
Heat shock 70kDa protein 4 HSPA4 aagacactgaggtctggctgta gggttggccaaggttctt 
Insulin induced gene 1 INSIG1 atcaatcacgccagtgctaa accacagacccagagacagg 
 
The qPCR assay was optimized in regard of annealing temperature (e.g. 60°C) and the 
amplicons were tested by a 2% agarose gel electrophoresis. The gel was made by mixing 2% 
LE agarose (SeaKem, MedProbe, Oslo) with TAE buffer (100 mL) and stained by adding 2 
droplets of ethidium bromide (0.6 mg/L stock solution). Examination of the photography 
showed single bonds of expected size. 
Each primer pair was tested with four different concentrations of complementary DNA 
(cDNA); 10 ng/µL, 5 ng/µL, 2.5 ng/µL and 1.25 ng/µL to find the optimal concentration for 
further analyses. Both 2.5 ng/µL and 1.25 ng/µL gave satisfactory treshold cycle (CT) values 
between 17-30 for all primer pairs and 1.25 ng/µL was selected for further work. 
The amplification efficiency for each primer pair was tested with a 10 fold dilution series 
(e.g. 30 ng/µL, 3 ng/µL, 0.3 ng/µL, 0.03 ng/µL and 0.003 ng/µL) of one control sample and 
two exposed samples (Ag nano and AgNO3). A standard curve for each primer pair was 
generated and the slopes were used to calculate the amplification efficiencies (E). The 
calculated mean efficiency ranged from 1.91 to 2.19, which means that the templates were 
approximately doubled for each amplification cycle and with >91% efficiency. 
Isolated total RNA (with known concentrations) from the experimental groups were used for 
cDNA synthesis. RNA samples (4µL) were reverse transcribed to cDNA in respective wells 
on a 96 well PCR plate on ice using the master mix (16 µL) provided by the Superscript III 
Platinum Two-step qRT-PCR kit (Invitrogen). 
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The master mix was made by mixing 2X Reverse Transcription (RT) Reaction Mix (10 µL), 
RT Enzyme Mix (2 µL) and RNase Free water (4 µL) in Eppendorf tubes on ice for each 
reaction, with 11 reactions in total. 
The plate was centrifuged for 1 sec at 2000 rpm in a megafuge (Heraeus sepatech). First-
strand cDNA was synthesized in a Peltier Thermal Cycler-225 (MJResearch, Waltham, MA, 
USA); 10 min at 25°C, 42°C for 50 min, and 85°C for 5 min before the plate was chilled on 
ice. To exclude traces of RNA, the plate was treated with RNase H (1 µL) and incubated at 
37°C for 20 min. The cDNA was diluted in RNase free water to 1.25 ng/µL and stored at - 
20°C until required. 
2.10.1 Real-Time Quantitative Polymerase Chain Reaction 
The qPCRs for the 10 target genes were performed using SYBR Green. A master mix was 
made up for each primer pair with components provided in the SYBR Green RT-PCR 
Reagents kit (Applied Biosystems). The master mix contained SYBR Greener qPCR 
supermix (10 µL), 10 µM forward primer (0.5 µL), 10 µM reverse primer (0.5 µL) and 
RNase Free water (4 µL) that were mixed for each reaction in Eppendorf tubes on ice. 
Master mixes were added to each well (15 µL in each well) together with respective samples 
of previously synthesized cDNA (5 µL) on 96 well PCR plates on ice. Negative controls 
without reverse transcriptase (neg-rt) and master mix without template (neg-temp) were 
included on the plates to control the samples for genomic contamination (neg-rt) and 
generation of primer dimers (neg-temp). All samples were run in triplets. The plates were 
sealed with sterile plastic films, centrifuged for 1 sec at 2000 rpm and the assays were 
carried out in a Real-Time PCR machine (7900 HT Fast real-Time PCR System, AB Applied 
Biosystem) operating by the SDS 2.3 software (Applied Biosystems): 50°C for 2 min (UDG 
incubation), 95°C for 10 min (enzyme activation), 95°C for 15 sec (denaturation) and 60°C 
for 1 min (annealing and elongation). 
Dissociation curves were included in the end of each run to identify possible contaminations 
or formation of primer-dimers. A single peak at the melting temperature of the amplicons 
was observed for all plates as the one presented for the control samples and β-actin (Figure 
7), and indicate the absence of contaminations and primer-dimers. 
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Figure 7. Dissociation curve generated from the qPCR of the control samples and the reference 
gene (β-actin). The single peak at the ampliconʼs melting temperature indicate absence of 
contamination and primer-dimers. 
 
Reference genes are used for normalization prior to relative quantification of gene 
expression data and should not be affected by the treatment. The CT values generated for six 
in-house zebrafish housekeeping genes (β-ACTIN, EF1α, GAPDH, RNAP, RPL13α and 
SDHA) were analyzed in the GeNorm software (PrimerDesign Ltd, Southampton, UK) to 
identify the optimal normalizing gene for qPCR data using SYBR Green. The tested genes 
have been evaluated as suitable reference genes for zebrafish material and the stability of 
more than one reference gene were tested as recommended prior to a new qPCR assay (Tang 
et al. 2008). 
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The CT values were transformed into relative expression values by the ΔCT method 
described in the GeNorm Housekeeping Gene Selecting Kit Handbook (07/07) before the 
data were uploaded to the GeNorm software. The genes were ranked from left to right on a 
graph (Figure 8), with the highest expression stability to the right. 
Figure 8. Graph generated by the GeNorm software, which ranked the reference genes under 
investigation based on their average expression stability. The y-axis displays the average expression 
stability and the genes with increasing expression stability is ranked to the right on the x-axis. 
Of the most stable genes, it was β-ACTIN that was assessed to be among the most stable 
genes with average expression stability <0.22 and the lowest gene expression stability value 
and were selected for normalization of the gene expression data generated by the qPCR 
assays. 
The raw data generated in the SDS 2.3 software were uploaded to RQ manager 1.2 and the 
treshold was set manually for all genes. The β-ACTIN-normalized CT values were analyzed 
in Microsoft Excel 2003 by the Livak method (Livak & Schmittgen 2001) in order to 
determine the mean fold change of the target genes in the exposed samples relative to the 
fold change in the control group. Amplification efficiency near 100% of both target and 
reference genes are assumed in the Livak method and was verified by the previously 
performed serial dilutions. 
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2.11 Statistical analyses 
The statistical analyses were performed in Microsoft Exel 2003 and JMP 8.0 software (SAS 
Insitute Inc., Cary, NC, USA), and p-values ≤0.05 were considered as significant. 
Kaplan-Meier survival curves (proportion of survival at each time point) were estimated for 
all groups and the differences in survival between unexposed and exposed groups were 
investigated by the log-rank test (Kleinbaum & Klein 2005). The Cox’s (semi-parametric) 
proportional hazard model and likelihood ratio statistics (Kleinbaum & Klein 2005) were 
used to investigate the replicate tank effect. The nested analysis of the interacting effects of 
replicate tanks within exposures showed that this interaction was insignificant (p=0.86). The 
results include estimated risk ratios for all groups, which were estimated by comparing the 
survival (time to death) in the unexposed group versus survival in exposed groups. Risk 
ratios larger than 1 implies an increased risk in the exposed groups compared to the control 
(Cantor 2003; Kleinbaum & Klein 2005). 
Levene’s test was used to assess the homogeneity of variance in the length data and 
indicated an unequal variance. Mean length within replicate tank was used as observational 
unit it the statistical analyses. Differences in the mean length recorded in the exposed and 
unexposed groups were analyzed by Welch ANOVA (which allows unequal variance across 
group), before all groups were compared to control by non-parametric Kruskal-Wallis test. 
Student’s t-test was used to compare the differences in the mean log2 transformed fold 
change ratios of the 10 target genes analyzed by qPCR in the exposed groups versus the 
unexposed control (n=6). 
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3. Results 
3.1 Characterization of size and size distribution 
Large particles with mean hydrodynamic diameters of 484 nm were found in the sample of 
conditioned water (appendix A). 
Table 4. Intensity-weighted mean hydrodynamic diameters (Z.avg), polydispersity indexes (PDI) and 
photon count rate (kilo-counts per second). 
Sample Z.avg (d.nm) PDI Count rate (kcps) 
Control 0 mg/L 1713 0,57 338 
Ag nano 0.01 mg/L 1345 0,37 142 
Ag nano 0.1 mg/L 227 0,37 157 
Ag nano 0.5 mg/L 179 0,33 114 
Ag nano 1.0 mg/L 165 0,37 315 
 
PDI values >0.1 indicate that there was a wide distribution of size in all samples. All 
samples contained particles of mean hydrodynamic diameters >100 nm. 
 
Figure 9. Volume distributions of relative light scattered by populations of particles in various size 
classes in the sample collected from the control group exposed to 0.0 mg/L silver nanoparticles. The 
y-axis shows the relative intensity of scattered light and particle size is presented on a logarithmic x-
axis. 
Mean size of the particles contributing to the three peaks displayed in Figure 9 were reported 
to be 87 nm, 1159 nm and 5163 nm, respectively. 
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Figure 10. Volume distributions of relative light scattered by two populations of particles in various 
size classes in the sample collected from the group exposed to 0.01 mg/L silver nanoparticles. The y-
axis shows the relative intensity of scattered light and particle size is presented on a logarithmic x-
axis. 
Mean size of the particles contributing to the two peaks displayed in Figure 10 were reported 
to be 32 nm and 1026 nm for the left and right peaks, respectively. 
 
 
Figure 11. Volume distributions of relative light scattered by particles of various size in the sample 
collected from the group exposed to 0.1 mg/L silver nanoparticles. The y-axis shows the relative 
intensity of scattered light and particle size is presented on a logarithmic x-axis 
Mean size of the particles contributing to the peak displayed in Figure 11 was reported to be 
10 nm. 
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Figure 12. Volume distributions of relative light scattered by two populations of particles in various 
size classes in the sample collected from the group exposed to 0.5 mg/L silver nanoparticles. The y-
axis shows the relative intensity of scattered light and particle size is presented on a logarithmic x-
axis 
Mean size of the particles contributing to the two peaks displayed in Figure 12 were reported 
to be 155 nm and 5590 nm for the left and right peaks, respectively. 
 
Figure 13. Volume distributions of relative light scattered by two populations of particles in various 
size classes in the sample collected from the group exposed to 1.0 mg/L silver nanoparticles. The y-
axis is the relative intensity of scattered light and particle size is presented on a logarithmic x-axis. 
Mean size of the particles contributing to the two peaks displayed in Figure 13 were reported 
to be 184 nm and 4777 nm for the left and right peaks respectively. 
Examples of the studied TEM images are presented in Figures 14 and 15. 
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Figure 14. Representative TEM image (14 kx magnification) of nanoparticles in the stock solution 
(1000 mg/L by mass of nanoparticles). Silver particles can be seen in black against the grey 
background. The scale bar is 1 µm, with black and white fields equal to 200 nm. 
The 14 kx magnification (Figure 14) of the dehydrated sample of the stock solution shows 
the presence of smaller particles in <200 nm and agglomerates. 
 
Figure 15. Magnified (56 kx) TEM images of nanoparticles in the stock solution (1000 mg/L by mass 
of nanoparticles). Silver particles can be seen in black against the grey background. Scale bars are 
200 nm, where each black or white field is 40 nm. 
TEM assessments of the stock solution at higher magnification identified agglomerates and 
smaller nanoparticles <40 nm. 
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3.2 Survival 
Kaplan-Meier plots (Figure 16) generated from the censored data depicts the differences in 
survival proportions in all groups at each time point during the study period. The log-rank 
test indicated that there was a significant difference between the survival curves of the group 
exposed to a nominal concentration of 1.0 mg/L by mass of silver nanoparticles compared to 
the control (log-rank p-value <0.01). 
 
Figure 16. Plot of Kaplan-Meier estimates of the survival proportions at any observed time point from 
6 dpf until 21 dpf in the respective groups. Time is represented by jump points and proportion of 
survival is represented by horizontal lines. The red curve represents the survival function of the 
control group (0 mg/L). It should be noted that the axes intercepts at y=0.4. 
Estimated survival curves descended rapidly around 11-12 dpf and flattened out around 16 
dpf in all groups. Percentage survival registred in the control group on 21 dpf varied around 
60 ±2% of the survival on 6 dpf. 
The likelihood ratio statistics identified exposure to be a significant explanatory variable for 
the overall differences in survival times (p-value <0.0001) and the significance of the 
replicate tank variable was found to be insignificant within all groups. 
Table 5. Estimated risk ratios, parameter estimates (β), standard error (SE) and significance of the 
exposure for the differences in the survival time compared to the survival in the control. 
Experimental group n β SE Risk ratio p-value 
AgNO3 0.01 mg/L 520 0.10 0.07 0.83 0.16 
Ag nano 0.01 mg/L 520 -0.01 0.07 0.01 0.93 
Ag nano 0.1 mg/L 520 0.05 0.07 0.91 0.48 
Ag nano 0.5 mg/L 520 -0.12 0.07 1.26 0.11 
Ag nano 1.0 mg/L 520 -0.28 0.08 1.76 <0.01* 
* Significantly different from the survival in the control 
* 
*Significantly different from control 
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There were estimated risk ratios >1 for the groups exposed to 0.5 mg/L and 1.0 mg/L silver 
nanoparticles. Exposure to 1.0 mg/L AgNPs was revealed to have a significant effect on the 
survival of zebrafish larvae exposed from 6 dpf – 21 dpf. 
3.3 Growth 
In order to detect any significant effects on growth (e.g. body length) after exposure to four 
concentrations of silver nanoparticles or silver nitrate (0.01 mg/L) the mean length in each 
replicate tank was measured on 21 dpf (Table 6). 
Table 6. Recorded mean body length (cm) on 21 dpf after exposure to silver nanoparticles (Ag nano) 
or silver nitrate (AgNO3) from 6 dpf – 21 dpf. N=number of larvae exposed from the beginning of the 
study period. The Kruskal-Wallisʼ ANOVA p-values indicate if the mean length of the exposed larvae 
was significantly different from the control. 
Experimental group n Mean SEM p-value 
Control 5 0.486 0.005  
AgNO3 0.01 mg/L 5 0.474 0.003 0.12 
Ag nano 0.01 mg/L 5 0.492 0.004 0.35 
Ag nano 0.1 mg/L 5 0.494 0.003 0.21 
Ag nano 0.5 mg/L 5 0.489 0.006 0.68 
Ag nano 1.0 mg/L 5 0.483 0.003 0.60 
 
No significant differences were found in the mean length between replicate tanks in any of 
the groups (p-values> 0.05). 
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3.4 Microbiological analysis 
Total number of bacterial colonies in samples from each group incubated on blood agar and 
plate count agar. 
 
 
Figure 17. Number of colony forming units per mL (y-axis) counted in water samples (x-axis) 
incubated at 30°C for 24 h on blood agar (BA) and plate count agar (PCA). The y-axis is in the 
logarithmic scale to base 10. 
The highest number of colonies per mL was counted in the water sample from the group 
treated with 1.0 mg/L silver nanoparticles, with 1.02 x106 and 3.04 x106 bacterial forming 
units per mL after incubation for 24 h on BA and PCA respectively. 
3.5 Changes in gene expression 
A total of 65 genes (appendix D) were found to be significantly affected by the exposure to 
silver nanoparticles (0.01 mg/L) relative to control (adjusted p-value <0.05), and a total of 7 
genes (appendix E) by the same concentration of silver nitrate. 
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Analyzes of the gene expression profiles revealed that 31 of the identified genes were unique 
for the group exposed to nanoparticles (Table 7), whilst silver nitrate did only significantly 
affect the transcription of 2 unique genes (Table 8). Two genes were found to be 
significantly induced in both exposures, i.e. glycoprotein 2 (GP2) and phosphodiesterase 6H 
(PDE6H).  
Table 7. Unique genes affected in larvae exposed to silver nanoparticles. 
Agilent Gene 
ID Entrez Gene Name 
Gene 
product 
(mammalian) 
Fold 
change  
A_15_P735641 
 angiotensin I converting enzyme (peptidyl-dipeptidase 
A) 1  ACE -0.979 
A_15_P720576  aquaporin 9  AQP9 -0.460 
A_15_P433820  basic helix-loop-helix family, member e41  BHLHE41 -0.945 
A_15_P111782  CD36 molecule (thrombospondin receptor)  CD36 -0.655 
A_15_P118478  cell division cycle associated 7  CDCA7 -0.682 
A_15_P105520  cryptochrome 2 (photolyase-like)  CRY2 -1.125 
A_15_P112968 
 E74-like factor 3(ets domain transcrip. factor, epithelial-
specif.)  ELF3 -0.635 
A_15_P193916  G protein-coupled receptor kinase 7  GRK7 -0.856 
A_15_P688556  guanylate cyclase activator 1C  GUCA1C -0.984 
A_15_P664406  heterogeneous nuclear ribonucleoprotein H1 (H)  HNRNPH1 0.488 
A_15_P667826  low density lipoprotein receptor-related protein 1  LRP1 0.420 
A_15_P151491  minichromosome maintenance complex component 2  MCM2 0.451 
A_15_P184201  meprin A, alpha (PABA peptide hydrolase)  MEP1A -0.509 
A_15_P759761  NPC1 (Niemann-Pick disease, type C1, gene)-like 1  NPC1L1 -0.552 
A_15_P110290  nuclear receptor subfamily 1, group D, member 1  NR1D1 -1.247 
A_15_P160041  nucleoporin 50kDa  NUP50 0.417 
A_15_P188606  nucleoredoxin-like 1  NXNL1 0.351 
A_15_P119429  opsin 1 (cone pigments), long-wave-sensitive  OPN1LW 1.793 
A_15_P103795  orthodenticle homeobox 2  OTX2 0.512 
A_15_P104502  period homolog 1 (Drosophila)  PER1 -1.153 
A_15_P121311  polymerase (RNA) I polypeptide A, 194kDa  POLR1A 0.391 
A_15_P111652  polymerase (RNA) II (DNA directed) polypeptide D  POLR2D 0.573 
A_15_P492197  replication factor C (activator 1) 3, 38kDa  RFC3 0.395 
A_15_P747151  rhodopsin  RHO 0.903 
A_15_P105466  ribonucleotide reductase M1  RRM1 0.733 
A_15_P113819 
 solute carrier family 15 (oligopeptide transporter), 
member 1  SLC15A1 -0.712 
A_15_P659881  SUB1 homolog (S. cerevisiae)  SUB1 0.587 
A_15_P103789  L-threonine dehydrogenase  TDH -0.976 
A_15_P166596  thyrotrophic embryonic factor  TEF -0.561 
A_15_P100927  transmembrane and coiled-coil domains 1  TMCO1 -0.352 
A_15_P628481  thioredoxin-related transmembrane protein 3  TMX3 -0.676 
 
Cardiovascular disease, genetic disorder, hematological disease, hypersensitivity response 
and ophthalmic disease were identified by IPA to be associated with the gene expression in 
the group exposed to silver nanoparticles. 
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Genetic disorder, ophthalmic disease, gastrointestinal disease and inflammatory disease were 
identified to be associated with the exposure to silver nitrate. 
Table 8. Unique genes affected in the larvae exposed to silver nitrate. 
Agilent Gene ID Entrez Gene Name Gene product (mammalian) Fold change 
A_15_P142661  Rh family, C glycoprotein  RHCG  −0,846 
A_15_P401105  synaptic vesicle glycoprotein 2B  SV2B  −0,414 
 
3.5.1 Toxicological pathways 
IPA identified toxicological pathways most significant for the uploaded genes. 
Table 9. Toxicological pathways most associated with genes with most significant fold change in the 
group exposed to silver nanoparticles. Fisherʼs p-value gives the significance of the annotated 
pathway and ratios give the number of total molecules known to be involved in the same pathway. 
Pathway Gene products (mammalian) p-value Ratio 
LXR/RXR activation CD36 1.01E-01 1/79 
Mechanism of gene regulation 
by peroxisome prolifirators via PPARa 
 CD36 1.85E-01 1/95 
PPARa/RXRa activation CD36  2.72E-01 1/170 
Cardiac hypertrophy ACE 4.16E-01 1/259 
 
IPA was not able to identify any toxicological pathways to be significant for the gene 
expression induced in the group exposed to silver nitrate. 
3.6 Validation of microarray results by qPCR 
Fold changes analyzed by microarrays were compared with fold changes detected by qPCR. 
The expression levels of three of the tested genes were identified to be significantly different 
in the exposed groups relative to expression in the control. Pearson’s correlation coefficient 
was estimated to 0.81 (p<0.01) for the two techniques. 
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Table 10. Fold change ratios for 10 target genes (n=6) analyzed by microarrays and relative fold 
change ratios of the same genes normalized for β-ACTIN expression analyzed by qPCR (n=6). Mean 
expression level of each gene in exposed groups was compared to the expression level in the control 
by the Studentʼs t-test. Gene names can be found in Table 3.  
Microarray qPCR ID Gene 
abbreviations 
Fold change      p-value Fold change          p-value 
AgNO3      
A_15_P113394 ABCA1 -1.267 0.33 -1.062 0.35 
A_15_P666681 BCAP31 -1.397 0.46 -1.092 0.03* 
A_15_P195261 BOD1 1.268 0.16 1.010 0.99 
A_15_P120264 PGD 1.243 0.35 1.071 0.53 
A_15_P621206 ZHX2 -3.03 0.44 -1.123 0.10 
Ag nano      
A_15_P468060 ALAS1 -1.593 0.14 -1.042 0.46 
A_15_P114663 AZIN1 1.293 0.64 1.197 0.03* 
A_15_P682056 HN1 -1.443 0.66 1.103 0.18 
A_15_P113537 HSPA4 1.289 0.39 1.088 0.06 
A_15_P620136 INSIG1 1.262 0.46 1.326 0.01* 
* Significantly different from expression in control
All genes analyzed by qPCR showed the same direction of up- or down-regulation as 
detected by the microarrays, but the magnitude differed to some degree. 
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4. Discussion 
4.1 Characterization of size and size distribution 
Based on results from both methods it appears that some of the primary particles were in the 
agglomerated state in the stock solution used for spiking of fish water. This initial 
polydispersity was reflected in the DLS characterization and it seems that there was a greater 
tendency for the nanoparticles to agglomerate in the highest concentration. Increased particle 
concentration is known to affect the rate of direct particle-to-particle interactions and result in 
increased rate and degree of agglomeration (Teeguarden et al. 2007). 
The intensity-weighted mean hydrodynamic diameters in Table 4 indicate that all particles 
were larger than 100 nm. DLS have been reported to be sensitive to the presence of 
aggregates or dust in samples (Kaszuba et al. 2008; MacCuspie 2011; Römer et al. 2011). It is 
evident from the figures displaying volume distributions of particle sizes contributing to the 
relative scattering (Figure 9-13) that there were large particles (or dust) of micrometer size 
present in all but the sample collected from the fish tank dosed with a nominal concentration 
of 0.1 mg/L. Based on the fact that the stock solutions were made from ultrapure water 
filtrated with a final filter of 50 nm it is apparent that these particles stem from the tank water, 
which is further indicated by the two peaks displayed in the figure for the control group 
(Figure 9) and is most likely excess feed and debris in the water. It appears from our results 
that scattering from these other particles become increasingly dominant with decreasing 
nanoparticle concentration and it is possible that this affected the reported mean 
hydrodynamic diameter (Table 4). 
Assessments of samples from the stock solution identified agglomerated particles even after 
sonication. It is possible that this is a result from the handling and preparation of samples and 
TEM images may not be an exact reflection of the size distribution administrated to the 
exposure tanks. 
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4.2 Survival 
An expected drop in survival was observed in all groups from around 10 dpf, which stabilized 
around 20 dpf. This is in accordance with previous reporting of a natural attrition rate 
experienced by zebrafish in this period (Andersen et al. 2003; Powers et al. 2010). 
Kaplan-Meier plots (Figure 11) and subsequent survival analysis shows that there was 
significantly better survival in the group exposed to the highest concentration of silver 
nanoparticles compared to the other groups. Treatment with silver nanoparticles at a 
concentration of 0.5 mg/L did also show a trend towards a positive effect on survival. 
However, this was not statistically significant. These observations are in contrast with 
previous findings were silver nanoparticles have been observed to induce a dose-dependent 
increase in mortality of zebrafish embryos (Asharani et al. 2008; Lee et al. 2007). Dose-
dependent increase in mortality has also been observed for medaka exposed to the same low 
levels of silver nanoparticles, and resulted in 100 % mortality at 0.8 mg/L (Wu et al. 2010). 
Our results indicate that exposure to low concentrations, which is predicted to be likely in the 
environment, may result in a positive effect on survival of fish larvae. 
The photon count rate reported from the DLS characterization indicated more agglomeration 
in the water sample collected from the same exposure group, and may indicate that 
agglomerated particles are less available or reactive towards fish, perhaps because of 
sedimentation. However, we did not observe any significant effects on changes in survival in 
any of the other groups that can substantiate this. Grey particles were observed on the bottom 
of all tanks dosed with silver nanoparticles in the present study. Analyses of water samples 
from tanks in other fish exposure studies have detected that the silver concentrations were 
lower (Griffitt et al. 2009; Scown et al. 2010), indicating that the larvae in this study might 
have been exposed to lower concentrations than the nominal concentrations. 
Previous studies of the effect of higher concentrations of silver nanoparticles on the survival 
of zebrafish resulted in an estimated LC50 (the concentration at which 50% of the individuals 
dies) value of 25-50 mg/L for zebrafish embryos (Asharani et al. 2008). Griffith et al. (2009) 
have estimated a no observed effect concentration (NOEC) on survival of adults to be 1.0 
mg/L, which indicate that there is a difference in susceptibility to lethal effects between the 
embryonic and adult stage of zebrafish. Differences in the route of uptake between the 
embryonic and adult zebrafish can be a possible reason for these differences. While uptake 
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over the skin has been observed in zebrafish embryos exposed to silver nanoparticles 
(Asharani et al. 2008; Yeo & Kang 2008; Yeo & Yoon 2009) uptake over gills and/or through 
the gastrointestinal tract from the water is suggested to be more important for free-swimming 
juvenile and adult fish of different species (Handy et al. 2008; Scown et al. 2010; Yeo & 
Yoon 2009). 
The results indicated that zebrafish larvae are not susceptible to lethal effects of low 
concentrations of silver nanoparticles or silver ions when exposed during larval development 
(6 dpf – 21 dpf). The low exposure concentration (0.01 mg/L) of AgNO3 resulted in the 
lowest proportion of surviving larvae, although not significantly lower than in controls 
(p=0.16). The present findings contrast with previous results reporting a significant decrease 
in survival in the same period (10 dpf – 21 dpf) after exposure to the same concentration of 
AgNO3 (Powers et al. 2010). 
4.3 Growth 
There was not observed any significant changes in growth (mean body length) of zebrafish 
larvae exposed to low concentrations of silver nanoparticles or silver nitrate compared the 
unexposed larvae on 21 dpf. It may be that this is a result of these larvae being more resistant 
to adverse effects in it surroundings compared to others that did not survive until 21 dpf. 
Based on these results it appears that exposures to predicted environmentally low 
concentrations of silver nanoparticles in this window do not affect the growth of larvae 
surviving until 21 dpf. 
The effect on growth was evaluated by Kruskal-Wallis test. Nonparametric methods requires 
great differences in the parameters tested between groups and have a tendency to result in a 
Type II error (accepting the null hypothesis when there is a significant difference) (Paulson 
2008). The risk of such a type II error could have been reduced if the length had been 
measured with a more fine-scaled tool. However, these findings are in accordance with other 
studies where the effects of silver nanoparticles on body length were found to be insignificant 
after exposure of Japanese medaka to concentrations in the same low-level range (< 1 
mg/L)(Bar-Ilan et al. 2009; Wu et al. 2010). 
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4.4 Microbiological analysis 
The antibacterial effect of silver nanoparticles have been suggested to be a possible 
explanation for a reported dose-dependent positive effect on body length and weight of 
juvenile medaka (Wu et al. 2010).  
The microbiological investigations showed that water samples from the group experiencing a 
positive effect on survival actually had the highest number of bacterial colonies, indicating 
that silver nanoparticles did not improved water quality by reducing the number of 
microorganisms. However, these assumptions are difficult to substantiate, considering that the 
differences in the level of microbes between and within treatments could not be compared 
statistically. 
4.5 Changes in gene expression 
A much higher number of genes were found to be significantly affected in larvae exposed to 
nanoparticles compared with silver nitrate. The number of genes that were identified to be 
unique for the two groups was almost double for the group exposed to nanoparticles 
compared to silver nitrate (Table 7 and 8), and indicates that nanoparticles induce different 
responses in the transcriptome of zebrafish larvae compared to silver ions from silver nitrate. 
This is in accordance with previous studies comparing the transcriptional profiles in small fish 
models following exposures to silver nanoparticles and silver nitrate (Chae et al. 2009; Griffitt 
et al. 2009; Griffitt et al. 2008; Laban et al. 2010).  
Two genes were found to be in common for both exposures, i.e. glycoprotein 2 (GP2) and 
phosphodiesterase 6H (PDE6H), which might result from dissolution of silver nanoparticles 
and the release of silver ions. We did not measure silver ion concentrations in any of water 
samples and are not able to exclude the possibility that nanoparticles worked by a silver ion-
mediated mode in regards to functions annotated by IPA to involve the expression of these 
genes that were in common. 
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4.5.1 Changes in gene expression following exposure to silver 
nanoparticles 
Cardiovascular disease and genetic disorder were identified by IPA to be highly associated 
with the gene expression profile induced the group exposed to silver nanoparticles. Most of 
the functions annotated to be involved with cardiovascular disease and genetic disorder in this 
study appeared to be connected to the gene encoding angiotensin I converting enzyme (ACE). 
This enzyme is involved in the renin-angiotensin-aldosteron system known to be involved in 
regulation of blood pressure and associated with the risk for developing cardiovascular 
disease (Lonn et al. 1994; Yusuf et al. 2000). Silver nanoparticles have been observed to 
affect the proliferation and angiogenesis of vascular endothelial cells in vitro (Gurunathan et 
al. 2009; Kalishwaralal et al. 2009; Rosas-Hernandez et al. 2009). It has been demonstrated 
that silver nanoparticles are capable of penetrating the skin and blood vessels of zebrafish 
larvae and induce effects on cardiogenesis (Yeo & Yoon 2009). Pericardial edema and effects 
on heart rate and circulation are frequently observed in studies of effects induced by silver 
nanoparticles on early development of small fish models such as zebrafish, fathead minnow 
and medaka (Asharani et al. 2008; Bar-Ilan et al. 2009; Laban et al. 2010; Lee et al. 2007; Wu 
et al. 2010). 
Ophthalmic disease was among the top 5 diseases found to be significantly associated with 
the transcriptional profile induced by nanosilver. Many of the most up- or down-regulated 
genes identified after exposure to silver nanoparticles are known to encode proteins involved 
in phototransduction (i.e. OPN1LW, RHO and GUAC1C and PDE6H). Interestingly, both 
cardiac and eye malformation were observed in zebrafish embryos exposed to silver 
nanoparticles in the same low dose-range as used in this study (Lee et al. 2007). Silver 
nanoparticles have also been observed to induce eye defects in Japanese medaka during larval 
development (Wu et al. 2010). 
IPA identified all four toxicological pathways to be significantly associated with the 
expression of CD36 (thrombospondin receptor) in larvae exposed to a low concentration of 
silver nanoparticles. CD36 is expressed in a variety of cell types, including macrophages, 
endothelium and smooth muscle cells and is involved in uptake of long-chained lipoproteins 
(Wood et al 2007). The liver X receptor (LXR), retinoid X receptor (RXR) and peroxisome 
proliferator activated receptor (PPAR α) are all ligand-activated nuclear receptors that induce 
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transcription of a variety of genes involved in regulation of many physiological processes 
(Woods et al. 2007). Expression of CD36 is known to be induced by activation of nuclear 
receptors such as PPAR and LXR (Chawla et al. 2001), indicating that exposure to silver 
nanoparticles involves the activation of such nuclear receptors. Considering that these 
pathways are known to be involved in uptake and efflux of lipids of the artery wall (Chawla et 
al. 2001; Sui et al. 2011) it seems that silver nanoparticle-induced changes in gene expression 
can affect cardiovascular health. 
Many of the molecules that were identified to be unique for the gene expression following 
exposure to silver nanoparticles appear to be highly connected in the top molecular network 
generated by IPA in the analysis of the gene expression of following exposure to silver 
nanoparticles. This network is included (Figure 18) to demonstrate the relationships.  
Several of the genes that were identified to be significantly differently expressed after 
exposure to silver nanoparticles are involved in the circadian rhythm signaling pathway (i.e. 
BHLHE41, CRY2, NR1D1, PER1), which appears to be connected with both 
phototransduction (involves OPN1LW, PDE6H, RHO) and cardiovascular disease (associated 
with CD36) (Hayasaka et al. 2010; Nonaka et al. 2001). The diurnal rhythm of several 
biological processes, including the expression of photoreceptors in the vertebrate eye and 
cardiovascular function (and disease) have been observed to be associated with changes in the 
circadian rhythm signaling system (Dalal et al. 2003; Nonaka et al. 2001; Whitmore et al. 
1998). CRY2, PER1 and BHLHE41 are all involved in the negative feedback-loop of the 
circadian rhythm pathway in both mammals and zebrafish (Cahill 2002). Both silver 
nanoparticles and nanoparticles of gold have just recently been observed to affect the 
expression of genes encoding for components involved in the circadian rhythm in rats 
(Balasubramanian et al. 2010; Minchenko et al. 2011), which may lead to disturbance of  the 
numerous processes regulated by this rhythmic signaling (Cahill 2002; Reppert & Weaver 
2001; Yu & Weaver 2011).
 58 
 
Figure 18.Molecular relationships in the top scored network identified by IPA. The intensity of the 
node color indicates the degree of up- (red) or down- (green) regulation. Dashed lines means that 
there is an indirect relationship between the molecules and full lines a direct relationship. All 
relationships are supported by at least one reference from the information stored in the Ingenuity 
Knowledge Base. 
 
4.5.2 Gene expression following exposure to silver nitrate 
IPA was only able to map 4 gene IDs from the silver nitrate group to objects in the Ingenuity 
Knowledge Base, which means that few genes were eligible for analysis. Expression of the 
GP2 gene was the only gene not identified by IPA to be involved in any of the annotated 
functions in the analysis, indicating that PDE6H, RHCG and SV2B were more central in 
regards to effects on gene expression induced by silver ions. Both RHCG and SV2B are 
 59 
glycoproteins. Silver has been reported to bind to sulfhydryl and sulphate groups of 
glycoproteins in epithelia of mussels after accumulation from sea water (George et al. 1986).  
The regulation of PDE6H in the group exposed to silver nitrate was assigned to function in 
ophthalmic disease, identified to be a highly significant function associated with the gene 
expression in the group exposed to silver nanoparticles as well. Coronary artery disease was 
identified as the toxicological pathway most significantly associated with the gene expression 
profile following exposure to silver nitrate, and was annotated to the expression of SV2B. 
Synaptic vesicle glycoproteins are involved in transport of neurotransmittors into synaptic 
vesicles (Feany et al. 1992) and it has just recently been proposed that synaptic vesicle 
proteins are also significantly expressed in endothelial cells of rat lung microvasculature (Li et 
al. 2011). Interestingly, have synaptic vesicle proteins just been proposed to be necessary for 
synaptic transmission in phototransduction (Oberstein et al. 2011), which was identified as 
significantly associated with the gene expression profiles of both the silver nanoparticle and 
silver nitrate group. This might indicate that both silver nanoparticles and silver ions induce 
changes in expression of genes involved in the visual and cardiovascular system, and points 
towards silver nanoparticles working by a similar mode as silver ions, perhaps through the 
release of ions at the target site. 
It should be noted that a majority of the functions and pathways identified by IPA to be 
significantly associated to the changes in gene expression have a fairly low ratio in regards to 
uploaded genes relative to total number of molecules known to be involved in the pathways. 
Gene expression pathways are complex and may result in other biological outcomes than the 
ones presented by IPA, which is based on available publications in the Ingenuity Knowledge 
Base. The literature in the Knowledge Base appears to focus on mammalian research. This 
bias may be reflected in the observations of IPA annotating cardiovascular disease as most 
significant for many of the most up- or down-regulated genes, which is a human disease that 
has gained a lot of attention in the past years. 
Quantification of mRNA levels by microarrays can be used to assess the functional state of 
cells, but do not include translational processes that may modify the level and function of the 
final proteins (Choi et al. 2010; White & Salamonsen 2005). Microarrays and analyzes of 
microarray data by applications such as IPA may be useful for designing hypothesis for 
further testing. By combining microarrays with studies of the proteome and endpoints at 
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higher organisational levels it may be possible to validate the mapped functions and evaluate 
the toxicological outcome.  
4.6 Validation of microarray results by qPCR 
Fold changes of 10 target genes were quantified by qPCR to investigate if the microarray 
results could be validated by a different quantitative technique. The fold change ratios showed 
the same direction of regulation, but differed to somewhat in magnitude of up- or down-
regulation (Table 10). A Pearson’s correlation coefficient of 0.81 indicated that the 
microarray results correlated well with the results obtained from qPCR.  
Selection of genes for validation by qPCR was based on unadjusted p-values <0.05 and means 
that they were not significant after correction for multiple testing. Three genes were found to 
be significantly differently expressed in the exposed groups relative to the control based on 
results from the qPCR, and contrast with the results for the same genes analyzed by 
microarrays. Real-time qPCR is known to be very sensitive and does not require as much 
processing of the data as the microarrays, which is evident from these results (White & 
Salamonsen 2005). 
4.7 Ecological relevance 
In this study we wanted to evaluate effects of silver nanoparticles at environmentally relevant 
concentrations. Based on the findings in this study it is implied that silver nanoparticles will 
not result in adverse effects on survival or growth of fish larvae exposed to concentrations 
ranging from 0.01 mg/L to 1.0 mg/L in the period they start foraging behavior.  
Metallic nanoparticles are expected to agglomerate and sorb to other particles or material in 
the water due to their high reactivity and raise a question about the bioavailability if released 
to aquatic environments (Brar et al. 2010; Klaine et al. 2008). It may also be that 
nanoparticles originating from use, wash or disposal of nanotechnology products will be 
retained in wastewater treatment plants and pose a bigger risk towards organisms in the soil 
environment exposed to wastewater sludge containing nanoparticles (Brar et al. 2010).  
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The present study observed silver nanoparticles to affect the expression level of genes 
involved in the feedback-loop of the circadian rhythm signaling pathway. PER1 and PER2 
have been shown to affect the transcriptional activation of CYP1A1 in mouse exposed to 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Qu et al. 2010) and the toxicological pathways 
annotated to the effects on changes in gene expression in the present study was connected to 
pathways involving several other ligand-activated nuclear receptors, thus pointing towards an 
interesting aspect that silver nanoparticles might affect the biotransformation and toxicity of 
other xenobiotics in the environment. 
 62 
5. Conclusion 
This study was carried out to evaluate the toxicity of silver nanoparticles at predicted 
environmentally relevant concentrations in a critical window of early life development of 
zebrafish larvae. 
Characterizations of the size and size distributions of the nanoparticles in suspension showed 
that they were polydispersed and agglomerating even after sonication. Size distributions of 
silver nanoparticles seem to increase towards bigger diameters with increasing concentrations 
when dispersed in fish tank water. The mean hydrodynamic diameter characterized by DLS 
looks to be affected by the presence of bigger particles in the exposure medium. 
The results demonstrates a trend towards low concentrations of silver nanoparticles having a 
positive effect on survival with increasing concentrations, with exposure to 1.0 mg/L resulting 
in a significant better survival compared to the control. Growth of larvae surviving exposure 
from 6 dpf – 21 dpf are not affected by low concentrations of silver nanoparticles or silver 
nitrate (0.01 mg/L). 
Exposure to silver nanoparticles (0.01 mg/L) induce significant changes in the expression of a 
much higher number of genes compared to silver nitrate. Both gene expression profiles appear 
to associate with the visual system and cardiovascular health. Silver nanoparticles induce 
changes in several genes involved in the negative feedback-loop of the circadian rhythm 
system and pathways associated with the activation of nuclear receptors. 
Estimated correlation between fold change ratios measured by microarrays and qPCR show 
that the two methods correlate well in regards to direction of up- or down-regulation and to 
some degree in magnitude, but qPCR seems to be more sensitive than microarrays in 
detecting significant differences. 
It is indicated from the microbiological analysis of water samples from the fish tanks that the 
differences in survival appear not be explained by a concentration-dependent antibacterial 
effect of silver nanoparticles. 
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Future work 
To investigate the size-specific effects and mechanisms of nanoparticles it is suggested that 
further emphasis should be on studies where the effects of nanoparticles are compared with 
bigger particles in the micro-meter size. 
Cardiovascular disease, phototransduction, processes connected to the expression of the fatty 
acid translocator (CD36) and circadian rhythm system appear to be associated with the 
changes in gene expression that were detected in the group exposed to silver nanoparticles 
(0.01 mg/L). It could be that effects on the gene level will manifest itself on a later stage of 
development and the significance of disturbances in these functions might be interesting to 
address in future studies. 
Considering that IPA could not map all the genes that were detected to be significantly up- or 
down regulated to objects in the Ingenuity Knowledge Base it would be interesting to 
examine which functions or pathways the unmapped genes are involved in. 
Dissolution of the nanoparticles and release of silver ions should be quantified. 
The microarray results should be validated by qPCR by analyzing 10 genes that are 
significantly differently expressed based on the adjusted p-values. 
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Appendix A: DLS characterization conditioned water 
Results from the DLS characterization of a sample of the conditioned water, which was used 
for diluting the stock solutions to required nominal concentrations. 
Table A.1. Mean hydrodynamic diameter, polydispersity index (PDI) and photon count rate (thousand 
counts per second) of particles detected in the conditioned water.  
Sample Z.avg (d.nm) PDI Count rate (kcps) 
Conditioned water 484 0,40 157 
 
 
 
Figure A.1. Volume distributions of relative light scattered by populations of particles in various size 
classes in the sample collected from the conditioned water used for dillutions of the stock solutions. 
The y-axis is the relative intensity of scattered light and particle size is presented on a logarithmic x-
axis. 
Mean size of the particles contributing to the two peaks displayed in Figure A.1 were reported 
to be 379 nm and 5305 nm for the left and right peaks respectively. 
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Appendix B: Raw data survival 
Table B.1. Number of surviving larvae recorded on a daily basis from 6 dpf – 13 dpf. Raw data from 
14 dpf – 21 dpf can be found in table B.2. 
Group 
Conc. 
(mg/L) Rep 6 dpf 
7 
dpf 
8 
dpf 
9 
dpf 
10 
dpf 
11 
dpf 
12 
dpf 
13 
dpf 
Control 0 A 52 52 52 52 51 49 41 38 
Control 0 B 52 52 52 52 52 49 40 37 
Control 0 C 52 52 52 52 51 46 43 36 
Control 0 D 52 52 52 52 52 48 40 35 
Control 0 E 52 52 51 51 49 47 41 35 
AgNO3 0,01 A 52 52 52 52 52 48 41 34 
AgNO3 0,01 B 52 52 51 51 48 44 37 34 
AgNO3 0,01 C 52 52 52 52 49 46 35 32 
AgNO3 0,01 D 52 52 52 52 49 47 34 27 
AgNO3 0,01 E 52 52 52 52 52 50 45 45 
Ag nano 0,01 A 52 50 50 50 50 49 45 33 
Ag nano 0,01 B 52 52 52 52 51 47 40 39 
Ag nano 0,01 C 52 52 52 52 50 45 41 36 
Ag nano 0,01 D 52 52 52 51 50 41 35 33 
Ag nano 0,01 E 52 51 51 51 50 47 43 38 
Ag nano 0,1 A 52 52 52 52 52 47 40 35 
Ag nano 0,1 B 52 52 52 52 48 44 38 36 
Ag nano 0,1 C 52 52 51 51 51 46 34 32 
Ag nano 0,1 D 52 52 52 52 51 48 41 35 
Ag nano 0,1 E 52 52 52 51 51 47 42 38 
Ag nano 0,5 A 52 52 52 51 51 49 41 40 
Ag nano 0,5 B 52 52 52 51 51 47 39 34 
Ag nano 0,5 C 52 52 52 51 50 45 39 37 
Ag nano 0,5 D 52 52 52 50 50 45 41 41 
Ag nano 0,5 E 52 52 51 50 50 47 44 40 
Ag nano 1 A 52 52 52 52 51 47 46 44 
Ag nano 1 B 52 52 52 52 52 50 46 44 
Ag nano 1 C 52 52 52 52 50 48 47 44 
Ag nano 1 D 52 51 51 51 51 49 46 45 
Ag nano 1 E 52 51 51 51 50 49 49 46 
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Table B.2. Number of surviving larvae recorded on a daily basis from 14 dpf – 21 dpf. 
14 
dpf 
15 
dpf 
16 
dpf 
17 
dpf 
18 
dpf 
19 
dpf 
20 
dpf 
21 
dpf 
35 35 35 35 34 33 32 30 
35 35 35 35 34 34 34 32 
35 35 34 34 34 34 32 32 
33 31 31 31 31 31 31 31 
34 34 33 33 32 32 32 31 
33 33 31 31 31 31 30 30 
34 32 31 27 26 26 26 26 
28 25 25 25 25 25 25 24 
26 24 24 23 23 23 23 23 
42 41 41 41 41 41 41 41 
32 31 31 30 30 28 28 28 
38 36 35 35 34 34 34 34 
36 35 35 35 34 34 34 34 
31 31 30 29 29 28 28 27 
37 36 36 35 35 35 35 35 
34 34 33 33 33 33 33 33 
36 35 35 34 34 34 32 32 
31 31 31 30 30 30 29 28 
34 31 30 30 30 29 28 25 
37 37 35 34 32 31 31 30 
40 40 40 38 38 38 37 36 
34 34 33 33 33 33 30 30 
36 35 35 35 35 35 35 35 
41 39 39 38 38 38 38 37 
40 40 40 40 40 39 39 38 
39 39 39 39 39 39 39 38 
44 43 41 39 39 39 39 39 
42 41 39 39 38 38 38 37 
44 42 40 40 39 39 39 39 
46 45 45 43 41 41 41 41 
 
 
Appendix C: Length data 
Length of each larvae surviving until 21 dpf was measured and mean length in each tank was 
used as observational unit. 
Table C.1. Mean length in each replicate tank on 21 dpf. 
Group Replicate tank n Mean Std.dev 
Control A 25 0,472 0,041 
Control B 32 0,477 0,042 
Control C 28 0,488 0,049 
Control D 30 0,495 0,060 
Control E 30 0,500 0,061 
AgNO3 0.01 A 28 0,476 0,049 
AgNO3 0.01 B 26 0,474 0,051 
AgNO3 0.01 C 23 0,485 0,043 
AgNO3 0.01 D 21 0,466 0,052 
AgNO3 0.01 E 33 0,472 0,051 
Ag nano 0.01 A 27 0,482 0,063 
Ag nano 0.01 B 32 0,497 0,059 
Ag nano 0.01 C 28 0,490 0,063 
Ag nano 0.01 D 26 0,504 0,054 
Ag nano 0.01 E 32 0,490 0,047 
Ag nano 0.1 A 31 0,489 0,067 
Ag nano 0.1 B 30 0,497 0,058 
Ag nano 0.1 C 22 0,496 0,042 
Ag nano 0.1 D 25 0,488 0,038 
Ag nano 0.1 E 26 0,502 0,053 
Ag nano 0.5 A 33 0,494 0,060 
Ag nano 0.5 B 28 0,503 0,055 
Ag nano 0.5 C 32 0,502 0,046 
Ag nano 0.5 D 34 0,471 0,060 
Ag nano 0.5 E 34 0,477 0,059 
Ag nano 1.0 A 33 0,493 0,071 
Ag nano 1.0 B 34 0,487 0,057 
Ag nano 1.0 C 34 0,481 0,064 
Ag nano 1.0 D 34 0,480 0,052 
Ag nano 1.0 E 35 0,476 0,058 
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Appendix D: Microarray results Ag nano 
Top tables (Table D.1 and Table D.2) with raw data displaying the significantly differently 
expressed genes identified following exposure to silver nanoparticles. Genes with log 
expression values (logFC) in-between -0.3 and 0.3 and average expression (AveExpr) under 
0.6 were excluded from the dataset. 
Table D.1. Significantly differently expressed genes identified in the group exposed to silver 
nanoparticles (0.01 mg/L). Expression values (log FC), average expression (AveExpr) and 
significance based on p-values adjusted for multiple testing assigned by limmaGUI. 
Name ID GeneName logFC AveExpr adj,P,Val 
ENSDART00000043507 A_15_P111207 si:ch211-284a13,1 -1,10699248 6,83754629 0,00052007 
NM_131577 A_15_P101039 arntl1a 1,02701244 6,69358944 0,00089664 
NM_205729 A_15_P110290 nr1d1 -1,24710023 7,64409873 0,00136078 
ENSDART00000043507 A_15_P177056 si:ch211-284a13,1 -0,87237631 7,04376232 0,0035406 
NM_131253 A_15_P117046 opn1mw1 0,97498916 8,174265 0,0035406 
NM_212439 A_15_P104502 per1b -1,15297452 8,16143591 0,00416137 
NM_194393 A_15_P688556 guca1c -0,98363909 7,70345935 0,00547377 
NM_001031841 A_15_P193916 grk7a -0,85553169 8,24474915 0,00547377 
NM_131400 A_15_P166596 tef -0,56059336 6,966742 0,00689295 
NM_201580 A_15_P160041 nup50 0,41652026 7,46160186 0,00689295 
NM_200692 A_15_P196411 ndrg1l 0,59211677 6,43636707 0,00689295 
NM_131786 A_15_P161566 cry3 -1,25801662 8,46270214 0,00738407 
TC396958 A_15_P753176 -1,27722289 7,43328583 0,00763601 
ENSDART00000114637 A_15_P403295 wu:fb81h03 -0,71296628 6,36433596 0,00763601 
NM_198064 A_15_P113819 slc15a1b -0,71219696 8,18463277 0,00763601 
NM_131788 A_15_P103946 cry5 -0,46623726 6,86524969 0,00763601 
NM_001076637 A_15_P118404 zgc:153034 0,53242536 7,30402384 0,00763601 
TC417879 A_15_P670036 -0,66401333 7,24811718 0,00764198 
BC044335 A_15_P133416 dnmt1 0,50907404 6,5524634 0,00764198 
NM_199972 A_15_P116591 elovl4b 0,5281247 7,00006294 0,00764198 
ENSDART00000060098 A_15_P399665 0,70845868 7,46649326 0,00764198 
EH438071 A_15_P513272 wu:fc15e02 -0,86021259 8,23956184 0,00808831 
NM_001159826 A_15_P404370 zgc:112320 -0,89681929 6,67810001 0,01090137 
NM_001002443 A_15_P119429 opn1lw2 1,79323705 8,16885304 0,01244836 
TC403556 A_15_P759761 -0,55192622 6,99794178 0,01317382 
NP13322337 A_15_P760451 -0,49891234 6,76020902 0,01396086 
ENSDART00000058699 A_15_P397660 LOC557984 -0,35567774 6,08922191 0,01396086 
BC096780 A_15_P263411 cry2b 0,71735068 6,84903972 0,01435172 
NM_001025188 A_15_P196306 zgc:110409 -0,55640454 6,67268753 0,0169118 
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Top table generated from the microarrays for the group exposed to silver nanoparticles is 
continued below. 
Table D.2. Significantly differently expressed genes identified in the group exposed to silver 
nanoparticles (0.01 mg/L). Expression values (log FC), average expression (AveExpr) and 
significance based on p-values adjusted for multiple testing assigned by limmaGUI. 
Name ID GeneName logFC AveExpr adj,P,Val 
NM_212637 A_15_P206111 mat2a -0,888807 8,32666673 0,01812927 
BC131854 A_15_P433820 bhlhb3l -0,94501184 6,90377511 0,02171458 
TC396958 A_15_P406095 -1,09082049 7,16238986 0,02285693 
ENSDART00000114501 A_15_P121311 -0,39147835 7,60031947 0,02390181 
CN322620 A_15_P554197 -0,59683605 6,10032449 0,02487935 
NM_001003598 A_15_P108422 nutf2 0,49189273 7,69581907 0,02487935 
TC391195 A_15_P112968 -0,63500327 8,2778159 0,02514456 
NM_001110760 A_15_P188606 nxnl1 0,35068263 6,32386585 0,02514456 
NM_001017574 A_15_P118478 zgc:110113 0,68205537 7,22266914 0,02514456 
NM_201457 A_15_P492197 rfc3 0,39469487 6,18706192 0,02709214 
NM_001033096 A_15_P720576 aqp9a -0,45972239 7,07600862 0,02785881 
CK015579 A_15_P772801 wu:fj84d10 -1,14689024 7,86856063 0,03156172 
NM_001109843 A_15_P666946 rhcgl1 -0,70826515 7,3554759 0,03197057 
NM_212589 A_15_P664406 hnrnph1l 0,48825044 7,65685433 0,03197057 
NM_131084 A_15_P213761 rho 0,77963347 11,2197711 0,03376626 
NM_001002575 A_15_P100927 tmco1 -0,35220868 7,15893122 0,03547341 
NM_131251 A_15_P103795 otx2 0,51203874 6,77910395 0,03547341 
BC125850 A_15_P177836 0,80747898 7,67617658 0,03547341 
TC388547 A_15_P735641 -0,97880223 6,59542861 0,03861332 
NM_001004618 A_15_P648216 zgc:103408 -0,3920372 8,25207287 0,03861332 
NM_173257 A_15_P151491 mcm2 0,45128834 8,16876209 0,03861332 
NM_001017803 A_15_P765676 zgc:111983 -0,74057985 8,29824929 0,04025804 
TC451970 A_15_P672296 -0,58965221 7,00836332 0,04150678 
TC388466 A_15_P678566 -0,46933043 6,47556659 0,04150678 
NM_001002317 A_15_P111652 polr2d 0,5734794 7,77580343 0,04150678 
NM_131455 A_15_P105466 rrm1 0,73271486 7,82232072 0,04150678 
NM_213245 A_15_P103789 tdh -0,97569941 8,71755423 0,04476046 
TC391598 A_15_P600272 -0,53770367 7,02320649 0,04476046 
BC044385 A_15_P118042 cry4 0,58411484 6,1908332 0,04476046 
BC165490 A_15_P659881 zgc:109973 0,58665359 7,36452006 0,04476046 
NM_001020557 A_15_P628481 tmx3 0,67561474 6,10455035 0,04476046 
NM_001128727 A_15_P184201 mep1a,2 -0,5092089 7,48768393 0,04650052 
BC093428 A_15_P770971 kif5a 0,54481471 8,24013659 0,04650052 
NM_001002363 A_15_P111782 cd36 -0,65515324 8,93708454 0,04733669 
ENSDART00000038471 A_15_P667826 0,4197346 6,81152107 0,04733669 
NM_131253 A_15_P153321 opn1mw1 1,21518898 8,38043916 0,04847486 
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Appendix E: Microarray results AgNO3 
Top table of raw data displaying the significantly differently expressed genes identified 
following exposure to silver nitrate. Genes with log expression values (logFC) in-between -
0.3 and 0.3 and average expression (AveExpr) under 0.6 were excluded from the dataset. 
Table E.1. Significantly differently expressed genes identified in the group exposed to silver nitrate 
(0.01 mg/L). Expression values (log FC), average expression (AveExpr) and significance based on p-
values adjusted for multiple testing assigned by limmaGUI. 
Name ID GeneName logFC AveExpr adj,P,Val 
NM_001159826 A_15_P404370 zgc:112320 -1,37498073 6,73677338 0,00109251 
NP13322337 A_15_P760451  -0,51957119 6,80499295 0,00214754 
NM_001082995 A_15_P401105 zgc:158677 -0,4140721 6,23068911 0,00295127 
NM_001089577 A_15_P142661 zgc:162132 -0,84644983 6,62590681 0,01569884 
EH550393 A_15_P378415  -0,70598627 7,77639999 0,01807794 
NM_212756 A_15_P151571 grn2 -0,61305622 8,97274013 0,02440055 
 A_15_P764346  -0,54247123 6,81119017 0,03484891 
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Appendix F: Raw data qPCR 
Raw data and calculations involved in the qPCR analysis are presented below. 
Table F.1. Amplification efficiencies calculated from the CT values and slopes of the standard curves 
generated from the 10 fold dilution of all primers. The percent efficiency is calculated by taking (E-1) 
times 100%. And an ideal reaction has E near 2. 
Gene Slope ctrl E control Slope exp E exposed Mean 
ABCA1 2.872 2.229 2.9994 2.155 2.192 
ALAS1 3.3114 2.004 3.2327 2.039 2.022 
AZIN1 3.6176 1.89 3.4576 1.946 1.918 
BCAP31 3.323 2 3.2391 2.036 2.018 
BOD1 3.4009 1.968 3.1258 2.089 2.028 
HN1 3.1711 2.067 2.793 2.281 2.174 
HSPA4 3.3311 1.996 3.3271 1.998 1.997 
INSIG1 3.1574 2.074 3.3393 1.993 2.033 
PGD 3.5196 1.924 3.5579 1.91 1.917 
ZHX2 3.1317 2.086 3.1844 2.061 2.073 
BACT 3.253 2.03 3.2401 2.035 2.032 
 
